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ABSTRACT 
 
Highly proliferating cells reprogram their metabolism in order to fulfill their requirements 
in biosynthetic precursors. One consequence of this metabolic adaptation is glutamine 
(Gln) addiction, a phenomenon whereby cells become dependent on Gln for their 
survival. How cells sense Gln levels and link this information to the survival machinery 
remains to be fully understood. Our laboratory previously showed that when Sp2/0-
Ag14 (Sp2/0) hybridoma cells were deprived of Gln, apoptosis is triggered within 
minutes. In this study, I used the Sp2/0 cell line to characterize the role which 
ammonium ions, a product of glutaminolysis, play in the modulation of cell survival. In a 
first series of experiments, I demonstrated that, when supplemented with ammonium 
salts, Gln-deprived Sp2/0 cell cultures showed a significant increase in viability. This 
effect of ammonium salts was independent of the cells’ ability to synthesize Gln, and 
was not affected by co-treatment with -ketoglutarate. In agreement with their effect on 
cell viability, ammonium salts caused a significant reduction in the number of Gln-
starved Sp2/0 cells with apoptotic nuclear condensation and fragmentation. 
Unexpectedly, supplementing Gln-starved Sp2/0 cells with ammonium salts did not alter 
cytosolic cytochrome c release, caspase-3 activation, DNA fragmentation or nuclear 
lamin A/C cleavage, indicating that the mechanisms triggering the apoptotic machinery 
remained intact. In a second set of experiments, I used the Gln antagonists 6-Diazo-5-
oxo-L-Norleucine (DON) and azaserine (AZA) to interfere with Gln metabolism in lieu of 
Gln deprivation. Both antagonists were toxic to Sp2/0 cells, an effect which was 
attenuated by supplementation with ammonium salts. This indicated that Gln 
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metabolism was required for cell viability, and that the effect of ammonium salts did not 
require metabolic pathways utilizing Gln. Unexpectedly, the supplementation of DON or 
AZA to Gln-starved cultured led to a small but significant increase in cell viability. 
Moreover, the supplementation with ammonium salts of Gln-deprived Sp2/0 cultures 
treated with DON or AZA caused a marked increase in cell viability. More importantly, 
the combination of ammonium salts and Gln antagonists resulted in a significant 
reduction in caspase-3 activation in Gln-starved Sp2/0 cells, indicating that they 
interfered with the apoptotic process. Altogether, our data demonstrate that ammonium 
ions trigger a pro-survival cellular response in Gln-deprived Sp2/0 cells. 
 
Keywords 
 
Ammonia, apoptosis, caspase, glutamine, glutamine addiction, glutamine analog, 
glutaminolysis, hybridoma. 
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1. INTRODUCTION   
1.1 Metabolic adaptation in actively proliferating cells 
 
One of the important factors for the cell’s decision to continue proliferation or commit to 
apoptosis depends on the metabolic activity and availability of nutrients (1). Actively 
proliferating cells show increased bioenergetic and biosynthetic needs in order to 
duplicate cell organelles as well as replicate DNA (2). This process requires abundant 
amounts of molecular building blocks such as nucleotides, proteins and lipids. In order 
to satisfy this need, proliferating cells must reprogram their metabolism (3). Quiescent 
cells depend on mitochondrial oxidative phosphorylation to generate ATP via the 
tricarboxylic acid cycle (TCA) and only under low oxygen, convert glucose to lactate 
through glycolysis for ATP production. Proliferating cells, however, catabolize glucose 
mainly through glycolysis, even in the presence of sufficient oxygen. This phenomenon 
is known as the “Warburg effect” (Figure 1-1) (4-7). As a result, glucose is metabolized 
to lactate with only two molecules of ATP per glucose molecule being produced 
compared to the 36 ATP molecules obtained via oxidative phosphorylation. This shift of 
metabolic reprogramming was puzzling as proliferating cells require a large amount of 
energy to grow and divide and yet selectively rely on glycolysis as a path for ATP 
production (8). In 1927, Warburg reported that the cellular metabolic change observed 
in cancer cells was due to defective mitochondria, which in turn impaired the ability of 
these cells to utilize glucose efficiently. However, due to our recent understanding of 
cancer metabolism, we know now that, in most cancer types and in normal actively 
proliferating cells, mitochondria are not defective in performing oxidative 
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phosphorylation. Nevertheless, proliferating cells reprogram their mitochondrial function 
through anabolic metabolism in order to ensure rapid ATP production, and to generate a 
continuous supply of biosynthetic metabolites needed for rapid growth and proliferation 
(2,3,9). 
 
 
Figure 1-1 Warburg effect 
In quiescent cells (left panel), glucose is metabolized through glycolysis and the 
tricarboxylic acid (TCA) cycle, generating 36 mol of ATP per mol of glucose. In contrast, 
in actively proliferating cells (right panel), glucose bypasses the TCA cycle in favor of 
biosynthesis to make membranes, amino acids and other macromolecules. From (9) 
Reprinted with permission from AAAS.  
 
This change in cellular metabolism characterizing actively proliferating cells is an 
outcome of the modulation of signaling pathways of modulating energy metabolism, 
high glucose uptake, as well as mitochondrial activities (10,11). Actively proliferating 
cells achieve this by overexpressing cell membrane glucose transporters (Glut-1) which 
allow increased glucose uptake. For instance, frequent activation of the Phosphoinositol 
3-kinase/protein kinase B (PI3K/AKT) pathway in cancer leads to increased 
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translocation of glucose transporters from intracellular vesicles to the cell membrane 
(12). Another way actively proliferating cells reprogram their metabolism is by increasing 
the expression of glycolytic enzymes and/or their isoforms, such as hexokinase (HK), 
pyruvate kinase (PK), phosphofructokinase (PFK) and others (13). PK, in particular, is 
very important as it catalyzes the reaction that converts phosphoenolpyruvate (PEP) to 
pyruvate, a step in glycolysis that produces ATP. There are different isoforms of PK, but 
the PKM2 isoform is predominantly expressed in cancer and proliferating cells (14) and 
is less effective at catalyzing the conversion of PEP to pyruvate. This results in 
accumulation of PEP, making upstream metabolites available to be shuffled into the 
pentose phosphate pathway (PPP) for the production of anabolic precursors, e.g., 
ribose and NADPH (13,14). The latter is needed for biosynthesis of macromolecules, 
such as fatty acids and cholesterol (9,15).  
 
 
This metabolic reprogramming is also modulated by (proto) oncogenes and tumor 
suppressors (Figure 1-2). In particular, changes in signaling pathways involving 
PI3K/AKT, p53 and Phosphatase and tensin homolog (PTEN) have been shown to be 
key to metabolic reprogramming (16-18). PI3K is a protein kinase whose activity is 
initiated by the activation of receptor tyrosine kinases. It leads to the activation of Akt, a 
serine-threonine protein kinase that activates several downstream targets such as 
FOXO and mTOR which dictate cell survival and proliferation responses (19-21). PI3K 
signaling also modulates mTORC1, a protein kinase complex which is implicated in 
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regulating many aspects of metabolic pathways as well as the promotion of protein 
synthesis and growth (22,23).  
 
Tumor suppressors also participate in regulating the metabolic adaptation observed in 
actively proliferating cells. For example, p53 inactivation can increase the levels of 
phosphoglycerate mutase (PGM) a glycolytic enzyme required for conversion of 3-
phosphoglycerate to 2-phosphoglycerate. This leads to elevated levels of glycolysis 
(24,25). Also, p53 can stimulate oxidative phosphorylation by inducing cytochrome c 
oxidase 2 (SCO2) synthesis and decrease the production level of reactive oxygen 
species (ROS) in the cell (26,27). Finally, PTEN, by acting as an inhibitor of PI3/AKT 
pathway, regulates the metabolic shift from oxidative phosphorylation to glycolysis (28). 
 
1.2 Glutaminolysis and its importance in the metabolism of actively 
proliferating cells 
 
As a consequence of the metabolic adaptations described above, glucose contributes 
less carbons to the TCA cycle. To replenish the latter, actively proliferating cells shuffle 
glutamine to the mitochondria where it is oxidized first to glutamate (via the enzyme 
glutaminase – GLS) and then to α-ketoglutarate (αKG) via glutamate dehydrogenase 
(GDH), a process known as glutaminolysis (Figure 1-3) (29,30). αKG can then be used 
to fuel the TCA cycle.  
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In addition to its role in replenishing the TCA cycle, glutamine is used as a precursor for 
the synthesis of several molecules essential to actively proliferating cells, such as 
NADPH, ribose, lipids and amino acids (Figures. 1.2 and 1.3) (31). This requirement for 
glutamine by actively proliferating has been termed “glutamine addiction” (32).   
 
 
Figure 1-2 Reprograming of metabolism in actively proliferating cells. 
A schematic representation shows the interaction between the oncogenes and tumor 
suppressors and signaling pathways that modulate different metabolic pathways in 
proliferating cells. From (9) Reprinted with permission from AAAS. 
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1.2.1 The modulation of glutaminolysis in actively proliferating cells 
  
In actively proliferating cells, glutaminolysis is tightly modulated by several factors, 
including p53, K-RAS and, most notably, MYC (16,33,34).   
 
1.2.1.1 p53 
p53 stimulates glutaminolysis by increasing Glutaminase 2 (GLS2) levels (33,35). 
Interestingly, in contrast to GLS1, which is associated with increased proliferation, GLS2 
is tumor suppressive (33,35). The molecular mechanism underlying this difference is 
unknown but may be linked to functions of these proteins unrelated to glutamine 
metabolism: for example, GLS2 has recently been shown to participate in the 
modulation of gene expression (36,37).   
 
1.2.1.2 K-RAS 
This oncogene has been shown to increase glutaminolysis through two different routes. 
Firstly, by increasing the expression of GDH, K-RAS ensures a sufficient input of 
glutamine-derived carbons into TCA cycle. Along with other changes in gene expression 
leading to the use of glycolytic intermediates in anabolic pathways (38), K-RAS 
expression results in a decoupling of glucose and glutamine metabolism in actively 
proliferating cells, allowing the latter to satisfy their requirements in biosynthetic 
precursors (39).  
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Secondly, K-RAS triggers the up-regulation of aspartate transaminase and, as a result, 
promotes the conversion of aspartate to oxaloacetate. The latter is then transformed 
into malate, which is used by malic enzyme to produce pyruvate and, importantly, 
NADPH (40).  
 
1.2.1.3 MYC 
As a transcription factor, MYC is known to modulate the expression of several genes 
required for the cell cycle and its regulation (e.g. Cyclins A, D1 and E; CDC25; 
p15INK4B), DNA synthesis (thymidine kinase) as well as metabolism (LDH-A) (41,42). 
More recently, MYC expression was shown to trigger the expression of genes 
responsible for increasing glutamine metabolism in proliferating cells (43,44). The role 
of MYC in modulating metabolic reprogramming was elegantly demonstrated by Wang 
et al. (43). Using mouse primary T cells, this group showed that T cell activation (by 
treatment with an anti-CD3 antibody) triggered a metabolic reprogramming typical of 
actively proliferating cells (i.e. aerobic glycolysis, increased glutaminolysis, increased 
glucose metabolism through the pentose phosphate pathway). Importantly, in T cells in 
which the MYC gene was deleted using a cre-lox system, both the metabolic 
reprogramming and cell proliferation upon activation were compromised (43).  
 
The control of glutamine metabolism by MYC in actively proliferating cells occurs at 
multiple levels. MYC increases the expression of the glutamine importers SLC1A5, 
SCL38A5 in a mechanism that apparently involves increased transcription (44). 
Moreover, MYC downregulates the expression of the miR-23a microRNA, which is itself 
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a negative regulator of GLS-1, and the glutamine importer SLC6A14 (45,46). MYC has 
also been shown to trigger the expression of glutamine synthetase (47), GLS-2 (48) and 
GDH (43).  It is therefore unsurprising that increased expression of MYC is a major 
contributor to glutamine addiction in proliferating cells.  
 
 
Figure 1-3 Glutaminolysis in actively proliferating cells 
In cancer and actively proliferating cells, glutamine is transported into the cell and is 
metabolized by glutaminase (GLS) to glutamate and ammonia. Glutamate is then 
converted to α-ketoglutarate by glutamate dehydrogenase (GDH) and enters the TCA 
cycle where it is metabolized to oxaloacetate (OAA). The latter condenses with acetyl-
CoA to form citrate. Malate produced during glutamine metabolism is converted to 
pyruvate by malic enzyme, generating NADPH. Pyruvate is subsequently metabolized 
to lactate by LDH resulting in NADH production (49). Reprinted under Creative 
Commons Attribution 4.0 International License. 
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1.2.2 Relevance of glutamine metabolism to cancer therapy 
 
Because of the central role played by glutamine in the metabolism and intracellular 
signaling of proliferating cells, the possibility of targeting glutamine metabolism as a way 
to cancer therapy has been suggested (Figure 1-5) (31,32,50,51). Therapeutic 
approaches can include depletion of glutamine from the blood, blocking glutamine 
transportation across the cell membrane, use of glutamine analogs or decrease the 
activity of enzymes necessary for glutamine metabolism (31).  
 
For example, the bioavailability of glutamine can be lowered by the use of 
phenylbutyrate which has been shown to prevent cancer cells from proliferating (52). In 
humans, phenylbutyrate is metabolized to phenylacetate, which in turn binds to 
glutamine to form phenylacetylglutamine which is excreted from the body (52-55). Use 
of L-asparaginase (ASNase), an enzyme that catalyzes the removal of the amide 
nitrogen from glutamine to form glutamic acid, is a part of the standard 
chemotherapeutic program to treat pediatric acute lymphoblastic leukemia (ALL), has 
proven to deplete glutamine by approximately 90% in the blood of ALL patients (56,57). 
Targeting the glutamine transporter, SLC1A5 by the L-glutamine analog l-γ-glutamyl-p-
nitroanilide, has been shown to inhibit cell growth and viability in lung cancer and 
human colon carcinoma cells (54,58,59). 
 
  
10 
 
1.2.2.1  Glutamine analogs 
The dependence of certain cancer cells toward glutamine has incited scientists to test 
structural analogs of this amino acid as a possible chemotherapy agent (51). Glutamine 
analogs act as irreversible inhibitors of glutamine-dependent enzymes by covalently 
attaching to the catalytic centers of these enzymes (51). Glutamine analogs were used 
to target glutamine in cancer therapy. In clinical trials, it was revealed that 6-diazo-5-
oxo-l-norleucine (L-DON) and azaserine (AZA), two glutamine analogs (Figure 1-4), 
were able to cause cytotoxicity in vivo in certain tumors. However, due to their severe 
toxicity, their use was discontinued (32,54,60,61). Nevertheless, since both DON and 
AZA block glutamine catabolism, they are frequently used to study the molecular basis 
of glutamine addiction (62). 
 
 
 
Figure 1-4 Structure of azaserine and DON 
 
 
 
  
11 
 
1.2.2.1.1 6-Diazo-5-oxo-L-norleucine (DON) 
 
DON was firstly described in 1956 as an antibiotic with antitumor activity isolated from 
an unidentified soil bacterial Streptomyces strain (63,64). DON has been used as an 
inhibitor of enzymes that utilize glutamine such as CTP synthetase (CTPS), carbamoyl 
phosphate synthase (CAD), glutaminase and others. These enzymes are involved in 
metabolic pathways such as the synthesis of purine, pyrimidine and amino acids 
(60,63,65-68). The effect of the antitumor capability of DON was investigated in several 
studies (68). DON was found to be effective in reducing several tumors if used alone for 
example in murine leukemia or with combination with azaserine in the case of mammary 
murine carcinoma (69) Recently, it was reported that the combination of DON with 
polyethylene glycol-conjugated glutaminase (PEG-PGA), a glutamine depleting enzyme, 
was very effective in a phase-II clinical study on advanced refractory tumors (70). DON 
can perturb the cell cycle as it causes S-phase arrest in some normal and neoplastic 
human cell lines (71). DON can also interfere with the function of cell organelles. DON 
was reported to cause disruption of the mitochondrial inner membrane in a 
neuroblastoma cell line as well as swelling of the endoplasmic reticulum, nuclear 
condensation, DNA strand cleavage and even apoptosis (72,73). DON can also inhibit 
growth in human carcinoid tumors and induce apoptosis through BAX in 
neuroblastomas and Ewing’s sarcoma cell lines expressing high levels of MYC (74,75). 
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1.2.2.1.2 O-diazoacetyl-L-serine (Azaserine) 
 
Azaserine is the most studied glutamine analog. Azaserine like DON, has antitumor 
activity and interferes with several metabolic processes within the cell.  Azaserine 
irreversibly inhibits glutamine amidotransferase, an enzyme required for ATP-dependent 
removal of the amido group from glutamine and transfers it to a specific acceptor. 
Azaserine also inhibits purine and cytidine synthesis (76,77). Azaserine was also 
reported to inhibit L-glutamine-D-fructose 6-phosphate amidotransferase (GFAT), an 
enzyme which catalyzes the conversion of fructose-6- phosphate to glucosamine-6-
phosphate using glutamine as the amine donor. Glucosamine-6-phosphate is then 
metabolized through the hexosamine pathway, leading to the formation of UDP-GlcNAc, 
a precursor for the synthesis of glycoproteins, glycolipids and proteoglycans (78,79). 
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Figure 1-5 Glutamine metabolism and possible cancer therapeutic targets 
Glutamine is transported into the cell and is metabolized to glutamate and ammonium 
ions by glutaminase which can be used for the production of building blocks required by 
the cell such as lipids and amino acids which in turn lead to cell growth via activation of 
the mTOR pathway. Several steps and components of glutamine metabolism can be 
targeted for cancer therapy which can be blocked by several pharmacological inhibitors. 
LAT1: L-type amino acid transporters 1, ASCT2: system ASC amino acid transporters 2, 
GLS: glutaminase, GDH: glutamate dehydrogenase. Reprinted under the Creative 
Commons Attribution License (31). 
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1.2.3 Glutamine and apoptosis 
 
Both normal and cancerous actively proliferating cells have been shown to depend on 
glutamine not only for growth and proliferation but also for their survival. In both rat and 
human neutrophils, glutamine has been shown to impede the initiation of apoptosis (80). 
Glutamine withdrawal triggers apoptosis in rat intestinal epithelial cells (81). Moreover, 
human pluripotent stem cells (iPSC) are dependent on glutamine metabolism for their 
survival (82). Several cancer cell lines (HEY, SKOV3, SF-188, MDA-MB-231 and 
SUM149) have been shown to undergo apoptosis upon glutamine deprivation 
(44,83,84).  
 
In order to better understand the role which glutamine plays on the control of apoptosis, 
a brief review of this mode of cell death is described below. I then describe some of the 
proposed mechanisms responsible for the modulation of cell survival by glutamine. 
 
1.2.3.1 Apoptosis  
 
Apoptosis, a type of programmed cell death (PCD), has many roles in multicellular 
organisms.  Apoptosis controls cell number during organism development and is a 
homeostatic mechanism by which cell population is maintained. Apoptosis is also the 
mean by which the immune system can rid the body of diseased or infected cells (1,85). 
Apoptosis is a process in which enzymes belonging to a family of cysteine-aspartic 
proteases (caspases) are activated either from within the cell or externally which leads 
  
15 
 
to distinctive morphological changes. These changes include nuclear fragmentation, cell 
shrinkage, chromatin condensation, membrane blebbing and the formation of apoptotic 
bodies.  The latter are subsequently engulfed and digested by macrophages (86-88). 
The distinctive morphological features of apoptosis are the result of biochemical 
reactions that happen in the cell. The main biochemical characteristics of apoptosis are:  
 
1) Externalization of phosphatidylserine (PS) from the inner side of the cell membrane 
bilayer. This externalization of PS allows the phagocytotic cell to systematically 
recognize apoptotic cells to eliminate them from the body (89). This event can be 
specifically detected by staining the cells with a fluorescently-labeled Annexin-V 
protein, which binds to PS. Annexin-V cannot enter through the intact cell 
membrane. Therefore, fluorescence detection can be used to detect the presence 
of apoptotic cells (for example, by flow cytometry or fluorescence microscopy) (90). 
 
2) Activation of initiator caspases which leads to subsequent activation of other, 
executioner caspases. The latter mediate the proteolytic cleavage of their 
intracellular substrates. Each caspase is activated in a specific step during 
apoptosis, and each caspase has several specific intracellular substrates (91). The 
caspase cleavage of substrates can be detected by different methods such as 
Western blot or the colorimetric detection of the cleavage of synthetic caspase 
substrates (1,92). 
 
3) During apoptosis, the genomic DNA is cleaved into fragments containing units of 
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approximately 140 nucleotides. This fragmentation can be seen as a ladder bands 
of fragmented DNA when using agarose gel electrophoresis (88). 
 
Apoptosis induction in mammals occurs through two main signaling pathways (93). The 
intrinsic or mitochondrial pathway, which can be triggered by different conditions within 
the cell including oxidative stress or DNA damage, converges at the mitochondria and 
leads to the formation of the apoptosome complex, which is responsible for the 
activation of the initiator caspase 9 (1). In contrast, the extrinsic pathway is initiated by 
stimuli from outside the cell which acts on the cell surface death receptors, leading to 
the activation of downstream initiator caspases 8 or 10 (Figure 1-6) (94).  
 
1.2.3.1.1 Intrinsic apoptotic pathway 
 
The intrinsic pathway can be triggered by numerous intracellular stimuli including DNA 
damage, cytoskeleton disruption, hypoxia and withdrawal of growth factors or nutrients 
(94). Responding to any of these apoptotic stimuli, pro-apoptotic BCL-2 family members 
are activated and lead to a critical step in the intrinsic pathway, the mitochondrial outer 
membrane permeabilization (MOMP). The initiation of outer membrane permeabilization 
is mainly mediated by the BCL-2 family protein members BAX and BAK, which 
oligomerize to form pores at the mitochondrial outer membrane.  A model called 
“rheostat” was suggested where the balance between anti-apoptotic and pro-apoptotic  
BCL-2 proteins act to regulate the involvement of mitochondria in apoptosis (95-98).  
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Once activated, BAX inserts itself into the outer mitochondrial membrane and 
oligomerizes with BAK to form pores, leading to MOMP (99). MOMP allows the release 
of a number of pro-apoptotic proteins from the mitochondrial intermembrane space 
(IMS) into the cytosol where they exert their role in the apoptotic cascade. Among these 
proteins are cytochrome c, Second Mitochondrial-Derived Activator of Caspases 
(SMAC/DIABLO), Apoptosis Inducing Factor (AIF), High-Temperature-Requirement 
Protein A2 (HTRA2/OMI) and Endonuclease G (Endo-G) (100,101).  
 
Once it is released into the cytosol, cytochrome c binds to apoptotic protease activation 
factor-1 (APAF-1). APAF-1 is an adaptor protein that contains a caspase-associated 
recruitment domain (CARD) and is present in the cytosol in an inactive form (102). The 
binding of cytochrome c to APAF-1 leads to a conformational change in APAF-1 
exposing the CARD domain which consequently promotes the CARD-CARD interaction 
with pro-caspase-9 to form a structure called the “apoptosome” resulting in caspase-9 
activation (103-105). Now, the active initiator caspase-9 is able to activate effector 
caspases, e.g., caspase-3 and caspase-7, which in turn cleave various cellular 
substrate leading to progression of apoptosis and ultimately cell death (106). Caspase-3 
can also activate other caspases including caspase-2, -6, -8 and -10 thereby 
propagating the apoptotic signal (107). X-linked inhibitor of apoptosis protein (XIAP) 
proteins can interfere with this process and inhibit the activity of caspase-3, -7 and -9 
(108).  
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1.2.3.1.2 Extrinsic pathway 
 
Activation of the extrinsic apoptotic pathway (Figure 1-6) is mediated by cell 
transmembrane receptors, known as Death Receptors (DR) which, upon binding to 
specific ligands, transmit an apoptotic signal inside the cell (1). Death receptors belong 
to the tumor necrosis factor receptor (TNFR) family and include TNF-R1, TRAIL, and 
FAS, among others (109). They contain a cysteine-rich  extracellular domain, necessary 
for specific ligand binding, and a cytosolic 80 amino acid domain called Death Domain 
(DD) (110,111). This family also includes the ligands of these receptors namely FASL, 
TNF and TRAIL.    
 
After ligand binding, death receptors trimerize and undergo a conformational change 
exposing their DD. The DD recruits a DD- containing adapter protein: while FASL/FAS 
binding recruits FAS-associated death domain protein (FADD), TNF/TNF-R recruits 
TNF-R1-associated death domain protein (TRADD). Then, FADD and TRADD, 
associated with pro-caspase-8 through a death effector domain (DED), leads to the 
formation of the death-inducing signaling complex (DISC) (112,113). In this complex, 
through close proximity, procaspase-8 is autocatalytically cleaved and activated 
(112,114,115). When activated, caspase-8 directly cleaves and activates caspase-3 
(116) resulting in the induction of the caspase cascade in the cell. Activation of 
caspase-8 can also involve the intrinsic pathway via cleavage of BID to a truncated form 
(tBID). tBID then translocates to the mitochondrial outer membrane (OMM) and induces 
MOMP, allowing the efflux of the pro-apoptotic proteins to the cytosol (115,117). 
However, activation of caspase-8 via DISC complex can be inhibited by the cellular 
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FLICE-like inhibitory protein (cFLIP) which also contains a DED domain by which it can 
block the recruitment of caspase-8 by the adaptor protein thereby inhibiting caspase-8 
activation (118). 
 
 
Figure 1-6 The extrinsic and intrinsic apoptotic pathways 
Apoptosis can be triggered upon binding of death ligand to death receptor which 
initiates extrinsic pathway and activation of death-inducing signaling complex (DISC). 
Caspase-8 can directly activate downstream caspases or cleave Bid. The intrinsic 
pathway is modulated by mitochondria and Bcl-2 proteins in response to various 
physiological signals. Upon the activation of pro-apoptotic Bcl-2 proteins, outer 
mitochondrial membrane permeabilization occurs and proapoptotic proteins, such as 
cytochrome c are released. Cytosolic cytochrome c binds apoptotic protease activating 
factor 1 (Apaf-1 and recruits procaspase-9 to form the apoptosome. Caspase-9 
activates downstream caspases (119).  
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1.2.3.2 Role of glutamine in apoptosis   
 
1.2.3.2.1 Modulation of the extrinsic pathway. 
 
Glutamine deprivation has been demonstrated in some cell lines to cause the induction 
of the extrinsic apoptotic pathways. In human monocytic U937 cells, glutamine 
deprivation significantly increased the cellular sensitivity to TNF and FASL (120). In 
the hybridoma cell line CRL-1606, glutamine starvation causes the up-regulation of 
FAS, along with the activation of caspase-8 (121).  
 
In CEM and HL-60 cells, glutamine deprivation triggers apoptosis through the FAS-
mediated activation of the extrinsic pathway (122). This process occurred in ligand-
independent manner. Because supplementation of glutamine-deprived cells with D-
glutamine could prevent the induction of apoptosis, the authors concluded that 
glutamine deprivation caused an osmotic stress. The resulting cell shrinking led to the 
clustering of FAS molecules and the subsequent activation of caspase-8. 
 
In another study, Ko et al. (123) have shown that glutamine deprivation sensitized HeLa 
cells to FASL-induced apoptosis. Interestingly, the underlying mechanism involved 
glutaminyl-tRNA synthetase (QRS), the enzyme responsible for charging the tRNAGln 
with glutamine. What Ko et al. uncovered is that in the presence of glutamine, QRS 
associated with and inhibited ASK1, a MAPKK activated as part of FAS-mediated 
apoptosis. Interestingly, glutamine deprivation disrupted the ability of QRS to inhibit the 
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activation of ASK1, providing an explanation for the increased cellular sensitivity to 
FASL.  
 
1.2.3.2.2 Modulation of the intrinsic pathway 
 
The observation that supplementation with glucose, but not glutamine, protects human 
neutrophils against FAS-induced apoptosis indicates that the modulation of the latter by 
glutamine is cell type-dependent, and that other cell death pathways are subjected to 
regulation by this amino acid (124). Effectively, a number of studies have revealed the 
induction of the intrinsic pathway following glutamine withdrawal (125).  
 
Using human and rat neutrophils, Pithon-Curi et al. observed that the induction of 
apoptosis following glutamine deprivation was associated with a decrease in 
mitochondrial transmembrane potential, indicating a loss of mitochondrial function (80). 
In human Jurkat T cells, glutamine supplementation led to an increase in BCL-2 
expression and in cell viability (126). Likewise, in several hybridoma cell cultures, 
glutamine deprivation triggers apoptosis that is inhibited by the ectopic expression of 
BCL-2 family members (127,128). Finally, glutamine starvation-induced cell death was 
shown to require BAX/BAK (129,130), to lead to caspase-9 activity (121,131,132) and to 
decrease the expression of HSP70, a heat shock protein known to impede intrinsic 
apoptosis at multiple levels (133-135). 
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1.2.3.3 Possible mechanisms of apoptosis induction by glutamine deprivation 
 
Aside from a few examples mentioned above where the experimental evidence 
suggests a possible mechanism (122,123), the molecular processes whereby glutamine 
promotes cell survival remain poorly understood. In particular, it is unclear how the cell 
senses glutamine levels and relays that information to the intrinsic apoptotic machinery 
to inhibit cell death. In the following section, I describe a number of possible ways 
whereby glutamine has been shown to modulate cell viability (Figure 1-7). 
 
1.2.3.3.1  Metabolism 
Considering its importance as a major energy source of actively proliferating cells, one 
would expect the modulation of survival by glutamine to be dependent on its catabolism.  
 
Using CEM human leukemia cells, Petronini et al. demonstrated that, while glutamine 
starvation triggered apoptosis, the extent of cell death was not affected when the 
glutamine-free medium was renewed daily (136). This suggested that glutamine 
deprivation did not trigger cell death through a decrease in intracellular energy levels. 
Confirming this study, Yuneva et al. showed that, while the combination of 2-
deoxyglucose (an inhibitor of glycolysis) and antimycin A (a potent inhibitor of oxidative 
phosphorylation) led to a much greater decrease in ATP levels in human intestinal 
epithelial cells than glutamine starvation, the latter was much more potent at inducing 
apoptosis (132).  
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Recently, Zhang et al. provided evidence that the knock down of citrate synthase 
prevented the induction of apoptosis in glutamine-deprived SF188 human glioblastoma 
cells (130). This indicated that the pro-survival function of glutamine did not depend on 
its oxidation through the TCA cycle. On the other hand, these investigators showed that 
cell viability in the presence of glutamine was compromised when the expression of the 
enzyme asparagine synthase (which synthesizes asparagine from aspartate and 
glutamine) was decreased by RNAi. Moreover, the induction of apoptosis following 
glutamine deprivation could be prevented by the simple supplementation of asparagine 
to the culture. How asparagine controls cell death has not yet been determined in detail, 
but Zhang et al. identified GADD153 as a pro-apoptotic protein the expression of which 
is downregulated by asparagine (130). Thus, at least in SF188 cells, glutamine 
modulates cell survival by ensuring an adequate supply of asparagine. 
 
1.2.3.3.2  Oxidative stress 
As a biosynthetic precursor of glutathione (GSH), glutamine plays a key role in 
protecting cells against oxidative stress (137). In a number of cell lines, including the 
HuH-7 hepatoma and Jurkat T cells, glutamine promotes cell viability through an 
increase GSH levels (126,138). However, this effect is cell-type dependent. For 
instance, work from our laboratory with the mouse hybridoma Sp2/0-Ag14 (Sp2//0) has 
revealed that, while glutamine deprivation triggered an oxidative stress that can be 
mitigated by the antioxidant N-acetyl-L cysteine (NAC), NAC treatment did not result in 
an increase in cell survival. Moreover, reducing GSH levels with the GSH synthesis 
inhibitor buthionine-[S,R]-sulfoximine (BSO) did not trigger Sp2/0 cell death (139), an 
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observation also made by Yuneva et al. in glutamine-deprived human intestinal 
epithelial cells (132). Interestingly, NAC could prevent the formation of apoptotic bodies 
and nuclear condensation and fragmentation in glutamine-deprived Sp2/0 cells, a 
phenomenon that involved the stress-activated protein kinase p38 (140). This suggests 
that, while it is not essential to the loss of cell viability, oxidative stress triggered by 
glutamine starvation may still play a role in modulating some of the late morphological 
events leading to apoptosis (139). 
 
1.2.3.3.3  The integrated stress response 
When challenged with certain stresses, the cell triggers an Integrated Stress Response 
(141,142). This phenomenon involves the activation of an eIF2-targeting, stress-
specific protein kinase: PERK (endoplasmic reticulum stress), PKR (viral infection), 
(HRI) (heme deprivation), and GCN2 (amino acid starvation) (141,142). Upon activation, 
these kinases will trigger a sequence of signaling events which will allow the cell to 
elaborate a stress response. 
 
Following amino acid starvation, GCN2 is activated in response to the accumulation of 
uncharged tRNAs (143,144). Upon activation, the ribosome-bound GCN2 
phosphorylates the alpha subunit of the translation initiation factor eIF2, locking the 
latter into a GDP-bound state and preventing cap-dependent translation initiation. 
Concurrently, a number of mRNAs containing short upstream open reading frame 
(uORF) in their 5’ untranslated region (5’ UTR) are translated. One of these mRNAs 
encodes the transcription factor ATF-4, which acts as a homodimer or as an 
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heterodimer with other protein partners (including one of its gene targets, CHOP-
10/GADD153) to modulate new gene transcription and lead to a stress adaptation 
response (141,142). A milder stress causes the up-regulation of amino acid transporters 
and biosynthetic enzymes, thus allowing the cell to survive. On the other hand, a more 
severe stress increases the expression of apoptosis-related proteins and results in cell 
death (141,142,145).  
 
 
 
 
Figure 1-7 Role of glutamine deprivation in apoptosis 
Apoptosis can be triggered by glutamine deprivation via different pathways. Glutamine 
deprivation can sensitize cells depending on cell type to the intrinsic pathway through 
mitochondria leading to activation of caspase-3 or extrinsic apoptosis pathway through 
Fas and TNF-α ligands that leads to activation of caspase-8. Glutamine deprivation 
sensitizes cells to JNK, ROS as well as inhibits HSP70. ROS: reactive oxygen species, 
JNK: c-Jun N-terminal kinase, HSP70: heat shock protein 70. Red ┴: inhibiting effect. 
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Several studies have linked the cellular response to glutamine starvation with the 
Integrated Stress Response. Acute glutamine deprivation has been shown to trigger 
GCN2 activation and/or eIF2 phosphorylation in several human cancer cell lines 
(129,146,147). Moreover, glutamine was shown by several teams to modulate the 
expression of CHOP-10 (130,147-149). Finally, Qing et al. demonstrated that the 
induction of apoptosis in glutamine-starved MYC-overexpressing cells was dependent 
on ATF4 and the ability of the latter to up-regulate the expression of the BH3-only 
proteins PUMA and NOXA (129).   
 
1.2.3.3.4  Glutamine and mTOR 
The mechanistic target of rapamycin (mTOR) protein kinase is at the core of a signaling 
pathway which responds to a variety of signals (e.g. low ATP levels, DNA damage, 
growth factors, hypoxia, nutrients) and uses this information to modulate cell 
proliferation, metabolism, autophagy and cell survival (150). For the sake of brevity, I 
have restricted my discussion on how the mTOR pathway responds to glutamine levels 
and how this can lead to a survival response. 
 
In the cell, mTOR forms two structurally and functionally distinct complexes, mTORC1 
and mTORC2, with mTORC1 being the best characterized of the two. In addition to 
mTOR, mTORC1 includes two other subunits, Raptor and mLST8. mTORC1 is 
recruited to the lysosome and requires its binding to RAG proteins, which are 
associated with the lysosomal membrane. mTORC1 is then activated by its amino acid-
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dependent association with Rheb, a guanine nucleotide exchange factor (GEF) protein 
localized to the lysosomes (145,150). Upon activation, mTORC1 phosphorylates a 
number of protein targets, leading to protein, lipid and nucleotide synthesis and to the 
inhibition of autophagy.   
 
mTORC2 is composed of three subunits: mTOR, Rictor and mLST8, and promotes cell 
proliferation and survival (150,151). The known protein substrates of mTORC2 are 
limited, and include AKT, SGK and members of the PKC family. In contrast to mTORC1, 
mTORC2 is insensitive to acute treatment by the antibiotic rapamycin, a property which 
is often used to distinguish between the contribution of these two protein complexes to 
specific cellular processes. 
 
Recent work has revealed that glutamine modulates the function of both mTORC1, with 
consequence to cell survival.  The cellular efflux of glutamine through the LAT1 
antiporter causes the influx of the amino acid leucine, a well-known mTORC1 pathway 
stimulator (152,153). Moreover, KG, produced from glutaminolysis, has been shown to 
be an activator of mTORC1 (152). Glutamine also promotes the recruitment of mTOR to 
the lysosome in a RAG-independent manner, via still undefined mechanisms involving 
the RAS family member ADP-ribosylation factor 1 (ARF1). Glutamine deprivation has 
been shown to lead to mTOR inhibition and to stimulate autophagy, a process through 
which cells digest their own organelles in order to obtain nutrients (154).  
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1.3 Research rationale, hypothesis and objectives 
 
The research program in our laboratory focuses on the elucidation of the cellular and 
molecular events underlying the modulation of cell survival by glutamine. I will first 
describe the cell model used in our studies. I will then provide the rationale to my 
research project, propose a working hypothesis and describe my research objectives. 
 
1.3.1 The Sp2/0-Ag14 cell line as a model to study the effect of glutamine on cell 
survival 
To investigate the modulation of cell survival by glutamine, our research group has used 
the mouse hybridoma cell line Sp2/0. This cell line has two interesting properties that 
make it a useful model to study the modulation of apoptosis by glutamine (131): 
 
1) It rapidly undergoes apoptosis upon glutamine starvation, with typical apoptotic 
morphological features being observed only 2 hours after the removal of the 
amino acid; 
 
2) Rapid Sp2/0 cell death is not observed when the cells are deprived of any of the 
other 19 amino acids. 
 
Efforts by our research group have revealed that glutamine starvation rapidly activates 
the intrinsic pathway in Sp2/0 cells: the release of the mitochondrial apoptogenic 
proteins CYT-C and SMAC/DIABLO is observed within 30 mins of glutamine withdrawal, 
followed by the recruitment of Bax to mitochondria and the activation of caspase-9 and 
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caspase-3 (131). Moreover, the glutamine-induced Sp2/0 cell death is potently inhibited 
by pro-survival BCL-2 family proteins (155).  
 
The acute response of Sp2/0 cells to glutamine starvation has been attributed to a 
combination of three features of this cell line: 
 
1) The low expression of GS: The Sp2/0 cells line, as well as hybridomas derived 
from it, have low expression of GLS (156). This limits the ability of these cells to 
synthesize glutamine, rendering them particularly vulnerable to the effects of 
glutamine starvation. 
 
2) Deregulated MYC expression: In several mouse hybridomas, including the Sp2/0 
cell line, MYC is expressed in a constitutive manner (128). In addition to its role 
in promoting metabolic reprogramming and glutamine addiction, MYC is well 
known to sensitize cells to apoptosis (157). Using normal human intestinal 
epithelial cells constitutively expressing a tamoxifen-responsive ER-MYC fusion 
protein, Yuneva et al. demonstrated that MYC expression significantly sensitized 
cells to apoptosis upon glutamine deprivation (132). Recent studies suggest that 
this phenomenon involves the up-regulation of the BH3-only proteins PUMA and 
NOXA (129), as well as the MYC-dependent, p53-mediated activation of the pro-
apoptotic protein BAK (158). 
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3) Restricted expression of pro-survival BCL-2 proteins: Work done in our research 
laboratory has shown that Sp2/0 cell line expresses relatively low levels of BCL-
2, BCL-xL and BCL-W (159,160). This is expected to reduce the threshold at 
which intrinsic apoptosis is triggered, and explains why the ectopic expression of 
BCL-xL is so potent at protecting Sp2/0 cells against cell death triggered by 
glutamine starvation and other toxic insults (140,155,159). 
 
 
On the other hand, Sp2/0 cells express high levels of MCL-1. Using two inhibitors of 
pro-survival BCL-2 proteins (Obatoclax and ABT-737), our group demonstrated that 
Obatoclax (which inhibits BCL-2, BCL-xL and BCL-W and MCL-1) sensitized Sp2/0 cells 
to glutamine deprivation-induced apoptosis (160). On the other hand, ABT-737 (which 
inhibits BCL-2, BCL-xL and BCL-W but not MCL-1), was much less toxic. 
 
1.3.2 Research Rationale 
While our laboratory has shown that glutamine deprivation causes the rapid induction of 
apoptosis in Sp2/0 cells, how these cells sense glutamine and use that information to 
block the initiation of the intrinsic apoptotic pathway remains to be uncovered.  
 
In a recent study, ammonium ions produced during glutaminolysis were shown to act as 
activators of autophagy, a phenomenon generally associated with cell survival (161). 
The authors also demonstrated that the combination of ammonium ions and -
ketoglutarate prevented the induction of apoptosis by TNF-(161).  
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For the most part, the investigation of the effect of ammonium ions on cells has focused 
on their toxicity. This is quite understandable, considering that increased blood 
ammonia (for example, following chronic liver disease) is toxic to astrocytes, glial cells 
and neurons and can therefore lead to brain dysfunction (162). A number of studies 
have investigated the cellular and molecular basis for the toxicity of ammonium ions on 
cells. Interestingly, many of them have revealed that ammonium ions affect cell 
behavior through the modulation of several signaling pathways known to be involved in 
the cell death/cell survival response.  
 
First, the hydrated radius of ammonium ions is very similar to K+ ions. As a result, 
ammonium ions compete with the cellular uptake of potassium ions (K+) through the 
Na+/K+-ATPase and Na+K+2Cl co-transporter (163-165), resulting in membrane 
depolarization and death. It is also worth noting that, since the efflux of K+ ions is known 
to activate apoptosis (166), ammonium ions are expected to modulate this type of cell 
death by interfering with K+ transport.  
 
Secondly, ammonium ions have been shown to trigger oxidative stress, a known trigger 
of apoptosis (167,168). For instance, ammonium ions cause mitochondrial dysfunction 
(169), increase the production of free radicals (170), cause the accumulation of protein 
carbonyl groups (an indication of oxidative stress) (171) and lower the concentration of 
the reduced form of the antioxidant glutathione (GSH) (171,172).  
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Thirdly, ammonium ions have been observed to affect the activation status and/or the 
expression levels of several protein kinases involved in cell survival or cell death 
pathways, such as Protein Kinase C (173-175), AKT (176), and the MAPKs p38 
(171,177-179) and ERK 1/2 (180). 
 
Finally, increases in p53 cellular levels (a well-known mediator of apoptotic cell death) 
were demonstrated both in vitro (181) and in vivo (182) after exposure to ammonium 
ions.  
 
Taken together, these observations raise the interesting possibility that ammonium ions 
contribute to the modulation of cell survival by glutamine.  
 
Previously unpublished studies in our research laboratory support this idea. We 
observed that, when cultured in the presence of 25 µM glutamine, Sp2/0 cells 
underwent apoptosis but in a more protracted manner compared to cells acutely 
deprived of the amino acid (183). Importantly, when Sp2/0 cells cultured in the presence 
of 25 µM glutamine were supplemented with 5 mM of ammonium acetate or ammonium 
chloride, a significant and reproducible increase in cell survival was achieved. This 
study also indicated that when ammonium acetate was used, but not ammonium 
chloride, reduced caspase-3 activation. Finally, Western blot and electron microscopy 
data suggested that supplementation of ammonium salts to Sp2/0 cells cultured in the 
presence of 25 µM glutamine led to an increase in the extent of autophagy in these 
cells. 
  
33 
 
 
Considering these observations, I hypothesized that ammonium ions, a by-product of 
glutamine metabolism, improve the survival of glutamine-starved cells by blocking 
apoptosis.  
To test this hypothesis, the following research objectives were pursued: 
 
 Research objective 1: Determine the effect of ammonium ions on the survival of 
glutamine-starved Sp2/0 cells. To this aim, glutamine-starved Sp2/0 cells were 
treated with ammonium ions. Cell viability was then assessed via several 
complementary approaches. 
 
 Research Objective 2: Determine the effect of ammonium ions on key 
components of the intrinsic apoptotic pathway in glutamine-deprived Sp2/0 cells. 
To this end, Sp2/0 cells which were deprived of glutamine and treated with 
ammonium salts were probed for the presence of morphological and biochemical 
apoptotic markers. 
 
 Research Objective 3: Considering that glutamine analogs have been shown to 
act as a surrogate for glutamine deprivation, determine whether ammonium ions 
also modulate cell survival in Sp2/0 cells treated with the glutamine analogs DON 
and AZA.  
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 Research Objective 4: Considering that glutamine analogs are competitive 
inhibitors of glutamine-metabolizing enzymes, I sought to determine whether 
DON or AZA would interfere with the ability of ammonium ions to improve the 
viability and reduce the apoptosis of glutamine-deprived Sp2/0 cells.  
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2. MATERIALS AND METHODS  
 
2.1 Chemicals and Reagents 
 
Unless stated otherwise, chemicals and reagents were purchased from Sigma-Aldrich 
Canada (Oakville, ON, Canada). Buffers and solutions were prepared using high quality 
H2O, which was filtered using a Millipore Milli-Q system. The composition of all solutions 
in this section is described in Appendix A. A 50 x stock solution of L-glutamine (200 
mM) was prepared with 1X PBS and filter-sterilized.  
2.2 Cell culture 
 
All cell culture experiments were performed in a laminar flow safety cabinet under 
aseptic conditions. The Sp2/0 mouse hybridoma cell line (ATCC # CRL1581) was 
obtained from the American Type Culture Collection (Rockville, MD). Sp2/0 cells were 
cultured in suspension in a humidified atmosphere at 37ºC and 5% CO2 in Iscove’s 
modified Dulbecco’s medium (IMDM), supplemented with 5% Fetalclone I (Hyclone, 
Logan UT), 100 U/ml penicillin, 100 µg/ml streptomycin and 4 mM L-glutamine 
(hereafter referred to as complete IMDM). During routine culture, cell concentration was 
kept between 50,000 to 800,000 cells/ml, which corresponds to exponential growth. In all 
cell culture experiments, Sp2/0 cells were cultured for a maximum of four weeks after 
which cells were discarded to avoid the selection of mutants with undesired phenotypes. 
The Ramos B lymphocyte cell line (ATCC # CRL-1596) was obtained from the American 
Type Culture Collection and maintained in Iscove’s modified Dulbecco’s medium 
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(IMDM), supplemented with 10% Fetal bovine serum (FBS), 100 U/ml penicillin, 100 
µg/ml streptomycin solution and 2 mM L-glutamine and cultured in a humidified 
atmosphere at 37ºC and 5% CO2. 
2.2.1 Cryopreservation and thawing of cells 
 
For long-term preservation, exponentially growing Sp2/0 cells were collected and 
resuspended in complete IMDM medium. Then, 2 x 106 cells were resuspended in 1 ml 
of cold complete IMDM medium supplemented with 10% (v/v) dimethyl sulfoxide 
(DMSO). Cells were frozen in cryovials overnight in a styrofoam container at -80ºC. The 
next day, the cryovials were transferred to a ThermolyneTM BioCane 20 cryo-container 
(ThermoFisher, Ottawa, ON) containing liquid nitrogen. When a new batch of cells was 
required, cells were retrieved from liquid nitrogen storage and rapidly thawed in a 37ºC 
water bath. Cells were then washed once with 10 ml of fresh pre-warmed complete 
IMDM  to remove the DMSO. The cells were centrifuged at 1,500 rpm at 25ºC for 5 
minutes, and the cell pellet was resuspended in fresh 10 ml of culture medium. Cells 
then transferred to 25 cm2 cell culture flask and cultured as mentioned above.  
2.2.2 Trypan blue exclusion assay. 
 
To determine the cell number as well as cell viability in a culture, an aliquot of cells 
was mixed with trypan blue solution (0.4%, v/v in PBS) and left for 5 minutes at room 
temperature.  Viable (clear) and nonviable (blue) cells were then counted using a 
bright-line hemocytometer. The average of at least four independent counts was used 
to calculate cell viability and cell number in the culture. 
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2.2.3 Rescue assay 
 
To test the effect of glutamine deprivation on the survival of Sp2/0 exponentially 
growing cells were collected by centrifugation and washed twice with pre-warmed 
IMDM supplemented with 5% FetalClone I, penicillin and streptomycin (hereafter  
referred to as glutamine-free IMDM), resuspended in glutamine-free IMDM at a density 
of 400,000 cells/mL and seeded in the wells of a 24-well culture plate. Control groups 
were supplemented with 4mM (final concentration) of glutamine. Where indicated, 
cultures were supplemented with 5 mM of AA or  AC with or without 1 µM of DON or 2 
µM of AZA at the start of the experiment. As controls, cultures were supplemented with 
PBS, 5 mM sodium acetate (SA) or sodium chloride (SC). Cells were then incubated 
for 3 hours at which point,  the cells were washed twice, resuspended in complete 
IMDM, and cultured for 24h. Viable and non-viable cells in each group were then 
counted using the trypan blue dye exclusion assay. 
2.2.4 Clonogenic assay 
 
As a complementary approach to measure cell viability, clonogenic assays were 
performed. In brief, cells were processed for glutamine starvation as described above. 
After 3h of glutamine deprivation, the cells were counted using a hemocytometer, 
diluted in complete IMDM to a density of approximately 5 cells /mL, plated into a 96-
well plate (0.5 cells per well) and cultured at 37ºC/5% CO2 for 10 days. Colonies 
consisting of more than 50 cells were then counted using light microscope. 
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2.2.5 Separation of viable from nonviable cells 
 
Separation of viable from nonviable cells was performed using Ficoll-Hypaque density 
gradient centrifugation (184). Cells were processed for a 3h glutamine deprivation 
experiment as described earlier. They were then collected by centrifugation at 2,500 
RPM for 5 min and resuspended in 2 ml of complete IMDM and then layered gently on 
10 ml of Ficoll-Hypaque cushion in 15 ml centrifugation tube. The tubes were then 
centrifuged at 600 RPM for 5 min at 10oC. After the centrifugation, the tubes were 
carefully removed from the rotor and, using a 1 ml micropipette, cells visible at the 
interface (live cells) were collected and transferred to a new 15 ml centrifugation tube. 
The pellet (dead cells) was also transferred into a different 15 ml centrifugation tube. 
Ten ml of complete IMDM was added to each tube and the cells were centrifuged for 5 
min at 2,500 RPM.  Finally, the supernatant was discarded, and the cells were 
resuspended in 2 ml of complete IMDM and counted using a hemocytometer. 
 
2.3 Apoptosis analysis 
2.3.1 Caspase 3 Colorimetric assay 
 
Caspase-3 activity was determined using the Apoptosis Colorimetric Assay kit 
(Biovision, Milpitas, CA), according to the manufacturer’s instructions. Briefly, 4x105 
cells were centrifuged at 2,500 RPM for 5 min at 25ºC and the cell pellet was 
resuspended in 50 µl of lysis buffer and incubated on ice for 10 min. Cells then were 
centrifuged at 12,000 RPM for 1 min at 4ºC then the supernatant was collected, and 
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protein concentration was determined using DC protein assay (Bio-Rad, Mississauga, 
ON). One hundred microliters of protein from each sample was transferred into a 96-
well plate in triplicate. 50 µl of 2x Reaction Buffer along with 5 µl of 4 mM DEVD-pNA 
substrate were added to each sample and then incubated at 37ºC for 2 hours. Caspase 
activity was then measured at a 405 nm wavelength in a PowerWave X microplate 
reader (Bio-Tek, Winooski, VT). Absorbance readings were taken every 30 min for a 
period of 2 hours. 
 
2.3.2 Flow cytometry analysis 
 
Apoptotic cells were detected using flow cytometry using the Annexin V-FITC Apoptosis 
Detection Kit (Biovision) according to the manufacturer’s protocol. Briefly, Sp2/0 cells 
were cultured for 2h in the presence or absence of glutamine at a density of 4x105 
cells/ml.  After incubation, cells were harvested by centrifugation for 5 min at  2,500 
RPM at 25ºC, washed once with 1x PBS and resuspended in 500 µl of 1x binding 
buffer. Five microliters of both Annexin V-FITC and propidium iodide (50µg/ml) were 
added to the cells and incubated at room temperature in the dark for 5 min. After 
incubation, the percentage of apoptotic cells (PI negative/Annexin V positive) and non-
apoptotic cells (PI negative/Annexin V negative) was assessed by flow cytometry using 
a BD FACSCanto II flow cytometer and the BD FACSDiva analysis software (BD 
Biosciences, Mississauga, ON). 
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2.3.3 DNA fragmentation analysis 
 
To assess apoptotic DNA fragmentation, 5 X 105 cells were harvested and washed 
once with PBS. Cells then were resuspended in 50 µl of lysis buffer, vortexed briefly 
and incubated for 5 minutes at 50ºC. Then 50 µl of loading buffer was added, and the 
mixture was vortexed briefly. Fifteen µl of each sample was loaded onto a 2% agarose 
gel and was run in TBE buffer at 95V for 45 minutes. After electrophoresis, the gel was 
stained with ethidium bromide (0.5 µg/ml) for 5 min, washed with H2O and then 
visualized with UV transillumination using a FluorChem Imager 8000 (Alpha Innotech, 
San Leandro, CA). 
2.3.4 Assessment of morphological changes in apoptosis 
2.3.4.1 Cell staining with Hoechst 33342 
 
Cells (4 X 105 / ml) were processed for glutamine deprivation as described previously. 
After 2.5 hours of deprivation, Hoechst 33342 was added at a final concentration of 2 µg 
and the culture was resumed for 30 min at 37oC.  After incubation, cells were placed on 
ice for 15 min and washed twice with PBS. Cells were collected by centrifugation at 
2,500 RPM for 5 min at 4ºC and placed on a microscope slide and sealed with a glass 
coverslip. Condensed and/or fragmented nuclei were visualized with a Zeiss Axiovert 
100 fluorescence microscope. Images were taken at 10x and 40x objective lenses. A 
minimum of 5 fields containing a total of at least 200 cells were counted.   
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2.4 Protein extraction and Western blot analysis 
2.4.1 Whole cell protein extraction: 
 
For each sample, 10 million Sp2/0 cells were collected by centrifugation at 2,500 
RPM for 5 min at 4ºC and then washed twice with PBS and pelleted at 2,500 RPM for 
5 min at 4ºC. The cell pellet was resuspended in 100 µl of RIPA lysis buffer and 
incubated on ice for 30 min. The mixture was then subjected to three cycles of 
freeze/thaw, where the samples were placed at -80ºC for 15 minutes and then 
immediately thawed at room temperature. The cell lysates were then placed on ice for 
30 min and centrifuged at 12,500 RPM for 20 min at 4ºC. The supernatant, which 
contains the whole cell protein extract, was transferred into another Eppendorf tube 
and the protein concentration was determined using DC Protein Assay Kit (Bio-Rad) for 
immediate use or stored at -80ºC until needed. 
 
For the analysis of PARP cleavage, proteins were extracted using a urea-based lysis 
buffer (185). The cell pellets were resuspended in the urea-based lysis buffer, subjected 
to sonication on ice for three intervals of 15 s using a Model 50 Sonic Dismembrator 
(Thermo-Fisher). After centrifugation (12,500 RPM, 20 min), the supernatant was 
collected and stored at -80ºC until needed. The protein extracts were heated for 15 min 
at 65oC before being subjected to PAGE-SDS electrophoresis.      
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2.4.2 Cytosolic protein extraction 
 
Ten million Sp2/0 cells were collected and placed on ice for 15 min, pelleted at 2,500 
RPM for 5 min at 4ºC and then washed twice with ice-cold PBS. The cell pellets were 
resuspended in 250 µl of buffer A  and placed on ice for 10 min. Cell lysis was 
assessed by staining cells with trypan blue. Cells were then centrifuged at 12,000 RPM 
for 5 min at 4ºC, and the supernatant was recovered and centrifuged again under the 
same conditions. Following centrifugation, the supernatant was recovered, 1 volume of 
2x RIPA lysis buffer was added, and this was used as the cytosolic fraction. Protein 
concentration was determined using DC Protein Assay kit and immediately processed 
for Western blotting or stored at -80ºC until needed. 
 
2.4.3 Determination of protein concentration 
 
The DC Protein Assay Kit was used according to the manufacturer’s instructions to 
measure the protein concentration in total or cytosolic protein extracts. Bovine serum 
albumin (BSA) standards (0.25 mg/ml - 2.0 mg/ml) were used to generate a standard 
curve. Each sample of unknown protein concentration was diluted to a ratio of 1:10 in 
RIPA lysis buffer. Five microliters of each BSA standard and sample was loaded in 
triplicate in the wells of a 96 well plate and 25 µl of reagent A and 200 µl of reagent B 
were added respectively. The mixture was incubated at room temperature for 15 min, 
then, the absorbance at 750 nm of each well was read using a Bio-Tek PowerWave-X 
microplate reader. 
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2.4.4 Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
(Tris-glycine) 
 
Protein separation was performed using 10% SDS-PAGE gel. Fifty micrograms of 
protein lysate from each sample in 1x sample buffer was boiled for 5 min, placed on ice 
for 2 min and then briefly centrifuged at 2,500 for 10 seconds at room temperature. The 
samples were then subjected to fractionation by electrophoresis using Bio-Rad Mini-
Protean II apparatus in 1x Tris-Glycine running buffer and run at 150 V for 90 min. A 
Precision Plus Protein Dual color ladder (BioRad) was also loaded onto the gel to 
confirm protein sizes. After that, gels were removed from the unit and placed in a 
transfer buffer for 5 min. The resolving and stacking gel compositions are listed below 
in table 2-1. 
 
Table 2-1 Composition and volumes for SDS-PAGE gels 
Reagent 
Separating Gel Stacking 
Gel 10% 12% 15% 
30% Acrylamide (ml) 5.0 6.0 7.5 0.65 
Tris/SDS pH 6.8 (ml) -- -- -- 1.25 
4Xtris/SDS pH 8.8 (ml) 3.75 3.75 3.75 -- 
dd H2O (ml) 6.25 5.25 3.75 3.05 
TEMED (µl) 10 10 10 5 
10% APS (µl) 50 50 50 25 
  
 
2.4.5 Tris-Tricine SDS-PAGE 
 
Tris-Tricine SDS-PAGE was used to separate proteins smaller than 20 kDa in size. 
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Protein samples were prepared as described above. A separating gel contained 12% 
Tris-tricine SDS-PAGE. The stacking gel contained 3.89% acrylamide and 2x Tris-
Cl/SDS  loading buffer. The gel was run at 30 mA for 3-5 h in a Mini-Protean II 
electrophoresis unit, and cathode buffer and anode buffer were used as running 
buffers. Below is the composition of separating and stacking gels in table 2-2. 
 
Table 2-2 Composition of Separating and Stacking Gels in Tricine SDS-PAGE 
Reagent Separating Gel Stacking Gel 
30 % Acrylamide (ml) 5.9 0.81 
Tris·HCl/SDS, pH8.45 (ml) 5 1.55 
H2O (ml) 0.515 3.89 
Glycerol 50% (ml) 4 -- 
10% APS (µl)  50 25 
TEMED (µl)  20 10 
 
 
2.4.6 Western blot analysis 
 
Proteins separated by SDS-PAGE were transferred to an Immobilon-P Polyvinylidene 
fluoride (PVDF) membrane (Millipore, Etobicoke, ON). All membrane transfers were 
performed using a TransBlot semi-dry transfer apparatus  (Bio-Rad). The PVDF 
membrane was immersed in 100% methanol for 15 seconds then presoaked in 
transfer buffer for 5 min. 3 MM Filter papers were cut to the same size as the PVDF 
membrane and also soaked in transfer buffer for 5 min. Protein transfer was set to 
run for 45-60 min at 15 volts. After the transfer was completed, the PVDF membrane 
was stained with Ponceau S for 5 min to determine the transfer efficiency and to 
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ensure that equal loading had occurred. The gel was also stained with Coomassie 
Brilliant Blue R-250 dye for a minimum of 30 min then placed in de-staining buffer 
until the background became clear. The PVDF membrane was quickly rinsed with 
water to remove the stain and immediately placed in 5% blocking buffer in TTBS 
buffer with gentle agitation for 1 h at room temperature. Primary antibodies were 
diluted in 5% blocking buffer at the indicated concentrations (Table 2-3) and then 
incubated with gentle shaking overnight at 4ºC. The next day, the membrane was 
washed three times 5 min in TTBS at room temperature and incubated with anti-
Rabbit Horseradish Peroxidase-conjugated secondary antibody (Cell Signaling 
Technology) diluted at 1:3000 in blocking buffer for 1 h at room temperature. The 
membrane was washed in TTBS as previously described and then incubated with 
chemiluminescent Immobilon Western HRP substrate (Millipore) for 5 min at room 
temperature. The chemiluminescent signal was finally captured using a Fluorochem 
8000 Imaging System. 
 
Table 2-3 List of primary antibodies used in SDS-PAGE immunoblotting 
Antibody Company and catalog # 
Final 
concentration 
Incubation 
conditions 
β-Actin Cell Signaling-4967 
1:1000 dilution  O/N at 4ºC 
Caspase-3 Cell Signaling-9662 
Cytochrome c Cell Signaling-4272 
HSP60 Cell Signaling-4869 
Lamin A/C Cell Signaling-2032 
PARP Cell Signaling-9542   
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2.4.7 Densitometry 
Densitometric analysis of the intensity of selected protein bands was performed using 
the AlphaEase software (Alpha Innotech). To measure the percentage of each protein 
band, level of loading control was used as a base for any variation in band intensity. 
 
2.5 Statistical analysis 
 
All experiments were independently performed at least three times on different days. 
Statistical significance of differences between study and control groups was 
determined by one-way ANOVA (Microsoft ExcelTM) where p values below 0.05 were 
considered statistically significant.  
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3. RESULTS 
 
3.1 Effect of ammonium ions on cell viability 
Our research team has previously shown that Sp2/0 cells display apoptotic biochemical 
features a few minutes only after being deprived of glutamine (131). Considering that 
glutamine-derived ammonium ions have been shown to exhibit pro-survival properties 
(161), I investigated whether the supplementation of ammonium ions could modulate 
the susceptibility of Sp2/0 cells to undergo apoptosis upon glutamine deprivation. 
 
3.1.1 Ammonium ions improve cell viability upon glutamine starvation 
I first tested the effect of ammonium ions on the viability of Sp2/0 cells in a 3h 
glutamine-deprivation rescue assay. In glutamine-deprived cultures supplemented with 
PBS, Sp2/0 cell viability was approximately 30%, which is similar to previously reported 
results from our group (131) (Figure 3-1). Interestingly, when glutamine-starved cultures 
were supplemented with 5mM ammonium acetate (AA) or ammonium chloride (AC), cell 
viability increased to 70% and 54%, respectively. Importantly, glutamine-deprived 
cultures supplemented with 5 mM sodium acetate (SA) or sodium chloride (SC) 
behaved similarly to the PBS-treated control. Finally, the fact that the ammonium 
ion/glutamine-supplemented groups showed cell viabilities similar to the PBS control 
indicates that, under our experimental conditions, ammonium ions did not have a toxic 
effect on the cells (Figure 3-1).  As is shown in Figure 3-2, the optimal protective effect 
of ammonium ions on glutamine-starved Sp2/0 was found to be 5mM.   
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Figure 3-1 Ammonium salts improve the viability of Sp2/0 cells cultured in Gln-
starved medium.  
Cells were deprived of glutamine (Gln) for 3h in the presence of 5 mM 
ammonium/sodium salt or an equivalent volume of PBS. Gln (4 mM) was then added 
and culture was resumed for 24 h. Cell viability was determined by trypan blue 
exclusion. Cultures in which Gln was added at the start of the experiment were included 
as controls. Data are the average ± SD of 3 independent experiments. * p<0.05 vs 
corresponding sodium salt- supplemented control.  S. chloride: sodium chloride. S. 
acetate: sodium acetate. A. chloride: ammonium chloride. A. acetate: ammonium 
acetate. 
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Figure 3-2 Dose response of different concentrations of ammonium salts on cell 
viability 
Sp2/0 cells were deprived of glutamine (Gln) for 3h in the presence of the 
concentrations stated above for ammonium acetate and ammonium chloride or an 
equivalent volume of PBS. Gln (4 mM) was then added and culture was resumed for 24 
h. Cell viability was determined by trypan blue exclusion. Cultures in which Gln was 
added at the start of the experiment were included as controls. Data are the average ± 
SD of 3 independent experiments. SC: sodium chloride. SA: sodium acetate. AC: 
ammonium chloride. AA: ammonium acetate. 
 
 
It is important to note that the cytoprotective effect of ammonium ions was not achieved 
when 5 mM of methylamine chloride, a structurally similar compound to ammonia, was 
supplemented to glutamine-starved Sp2/0 cells for 3 hours in a rescue assay, indicating 
that the pro-survival effect is specific to ammonium ions (Figure 3-3). 
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Figure 3-3 Methylamine has no effect on cell viability 
Sp2/0 cells were deprived of glutamine for 3h in the presence of 5 mM of methylamine 
or an equivalent volume of PBS. Gln (4 mM) was then added and culture was resumed 
for 24 h. Cell viability was determined by trypan blue exclusion. Cultures in which Gln 
was added at the start of the experiment were included as controls. Data are the 
average ± SD of 3 independent experiments.  
 
3.1.2 Ammonium salts improve cell viability in the presence of Glutamine 
analogs 
I first examined the effect of glutamine analogs on Sp2/0 cell viability. Sp2/0 cells were 
incubated for 24 hours in complete IMDM containing glutamine with 1 µM DON or 2 µM 
AZA alone and control groups were supplemented with PBS. Cell viability was assessed 
by trypan blue exclusion assay. Figure 3-4 shows that, while the viability of the control 
group was over 90%, Sp2/0 cells treated with DON or AZA had almost 80% dead cells. 
This confirms that interfering with glutamine-metabolizing pathways is sufficient to 
trigger cell death in this cell line, even in the presence of glutamine. 
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Figure 3-4 Glutamine-analogs, AZA or DON cause cell death in Sp2/0 despite the 
presence of glutamine. 
 
Cells were cultured with glutamine for 24h in the presence of 1µM of DON or 2µM of 
AZA which were added at the start of the experiment. Cell viability was determined by 
trypan blue exclusion. Data are the average ± SD of 3 independent experiments. DON: 
6-Diazo-5-oxo-L-norleucine, AZA: azaserine. 
 
I next tested the effect of ammonium ions on the viability of Sp2/0 cells treated with 
DON or AZA in the presence of glutamine. Sp2/0 cells were cultured for 24 h in 
complete IMDM in the presence of 2 µM AZA or 1 µM DON and 5 mM of AA or AC. 
Control groups were supplemented with PBS or the corresponding sodium salt. When 
Sp2/0 cells were treated with the combination of SC and DON or SA and DON a 
reduction in viability similar to the one observed in the presence of the glutamine analog 
alone was observed (Figure 3-5A). Interestingly, when cells were cultured for 24 h in the 
presence of  DON and either AA or AC, the viability was significantly higher compared 
to controls. Similar results were obtained when AZA was used (Figure 3-5B). Thus, the 
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sensitivity of Sp2/0 cells to glutamine analogs can be decreased by the supplementation 
with ammonium salts. 
A) 
 
B) 
 
Figure 3-5 Ammonium salts improve the viability of Sp2/0 in the presence of DON 
or AZA.  
Cells were cultured with glutamine for 24h in the presence of 5 mM ammonium/sodium 
salt or an equivalent volume of PBS. 1µM of DON or 2µM of AZA were added at the 
start of the experiment. Cell viability was determined by trypan blue exclusion. Data are 
the average ± SD of 4 independent experiments. *p<0.05 vs. DON or AZA. +p<0.05 vs. 
corresponding sodium salt- supplemented control. DON: 6-Diazo-5-oxo-L-norleucine, 
AZA: azaserine, S. chloride: sodium chloride. S. acetate: sodium acetate. A. chloride: 
ammonium chloride. A. acetate: ammonium acetate. 
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The above observations raised a question whether this protection against apoptosis, 
exerted by ammonia, is transient or whether it would lead to long-lived cells capable of 
proliferation. To address this question, I treated Sp2/0 cells with 5 mM of AA, AC, SA, 
SC and PBS for 3 hours in the presence or absence of glutamine and then processed 
them for a clonogenic assay. As seen in Figure 3-6, glutamine-starved cells treated with 
either AA or AC showed a significant increase in colony formation compared to the 
control groups, confirming that ammonium ions modulated the viability and preserved 
the proliferative capacity of glutamine-deprived Sp2/0 cells.  
 
 
Figure 3-6 Ammonium ions improve Sp2/0 cells proliferation in clonogenic assay 
Cells were deprived of glutamine for 3h in the presence of 5 mM ammonium/sodium salt 
or an equivalent volume of PBS. Cells were then processed for a clonogenic assay. 
Data are the average ± SD of 3 independent experiments. * p<0.05 vs. corresponding 
sodium salt- supplemented control. S. chloride: sodium chloride. S. acetate: sodium 
acetate. A. chloride: ammonium chloride. A. acetate: ammonium acetate. 
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When I looked at the data obtained, I noticed that glutamine-starved cells exposed to 
AA showed a greater cell viability compared to cells supplemented with AC (Figure 3-1, 
Figure 3-6). Therefore, I asked the question whether acetate contributes to the effect of 
ammonium salts by acting as a carbon source that can be used by the cell to maintain 
its metabolism. To address this question, I tested the effect of methyl pyruvate (MePyr), 
a membrane-permeant pyruvate analog, and glutamate, which are both substrates for 
the TCA cycle and ATP production, on the viability of glutamine-starved Sp2/0 cells. 
Therefore, I cultured Sp2/0 cells with or without glutamine for 3 hours and 
supplemented with 5 mM of AC in the presence or not of 4 mM MePyr.   
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A) 
 
B) 
 
Figure 3-7 Methyl pyruvate and glutamate have no effect on cell viability 
A) Sp2/0 cells were treated with 5 mM of each of the indicated compounds or an 
equivalent volume of PBS for 3 hours in the presence or absence of glutamine (Gln). 
The cells were then processed for the determination of viability by the rescue assay. B) 
A similar experiment was performed as in panel A. except that glutamate was used 
instead of MePyr. Data are the average ± SD of 3 independent experiments. * p<0.05 
vs. PBS. + p<0.05 vs. corresponding sodium salt- supplemented control. S. chloride: 
sodium chloride. S. acetate: sodium acetate. A. chloride: ammonium chloride. A. 
acetate: ammonium acetate.  
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I observed that the viability of cells treated with AC was significantly higher than cells 
treated with MePyr or PBS. However, the combination of AC with MePyr did not lead to 
a greater increase in the viability of glutamine-starved cells compared to the cells 
treated with AC alone (Figure 3-7A). Similar results were obtained when glutamate was 
used instead of MePyr (Figure 3-7B). These results suggest that the greater 
improvement of cell viability by AA is not due to presence of acetate as a carbon 
source. 
 
3.1.3 Non-additive effect of ammonium salts and α -ketoglutarate on the viability 
of glutamine-starved Sp2/0 cells 
 
To further investigate the effect of glutamine deprivation on cell viability, I investigated 
the role of α-ketoglutarate, another product of glutaminolysis. A rescue assay was 
performed where Sp2/0 cells were cultured in complete IMDM with and without 
glutamine and supplemented with 1 mM of α-ketoglutarate alone or in combination with 
AA, AC, SA or SC for 3 hours. The results show that α-ketoglutarate alone significantly 
improved cell viability in the absence of glutamine; however, there was no significant 
increase in viability when α-ketoglutarate was added with ammonium salts. This shows 
that there was no additive effect of α-ketoglutarate and ammonium salts on the viability 
of glutamine-starved Sp2/0 cells (Figure 3-8). These data suggest that the effect of 
ammonium ions on Gln-starved Sp2/0 cells viability is not the result of increased 
glutamine synthesis. 
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Figure 3-8 Non-additive effect of ammonium salts and α-ketoglutarate on the 
viability of glutamine-starved Sp2/0 cells 
Cells were deprived of glutamine for 3h in the presence of 2 mM dimethyl α-
ketoglutarate (αKG) and 5 mM ammonium/sodium salt or an equivalent volume of PBS. 
Cultures in which the solvent ethanol (Eth) was added in place of αKG were included as 
controls. Gln (4 mM) was then added and culture was resumed for 24 h. Cell viability 
was determined by trypan blue exclusion. Cultures in which Gln was added at the start 
of the experiment were included as controls. *p<0.05 vs. corresponding ethanol-
supplemented control. +p<0.05 vs. corresponding  sodium salt-supplemented control. 
Data are the average ± SD of 4 independent experiments. S. chloride: sodium chloride. 
S. acetate: sodium acetate. A. chloride: ammonium chloride. A. acetate: ammonium 
acetate. 
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3.1.4 Effect of ammonium salts on the viability of glutamine-starved Sp2/0 cells 
does not depend on glutamine synthesis  
 
Ammonium ions are produced during glutamine metabolism by conversion of glutamine 
to ammonia and glutamate by the enzyme GLS (186). Glutamine can be generated by 
an opposite reaction from glutamate and ammonium ions by the enzyme glutamine 
synthetase (GS) (90,187,188). Thus, I asked if the promotion of cell viability by 
ammonium ions was the result of increased glutamine production via GS. To answer 
this question, I used the GS inhibitor Methionine Sulfoximine (MSO) and again 
assessed cell viability during a glutamine-starvation rescue experiment. To confirm that 
MSO was functional, I first tested MSO on Ramos Burkitt's lymphoma cells, a MYC-
overexpressing cell line (189). The viability of Ramos cells deprived of glutamine for 24 
hours was significantly reduced in the presence of 10 mM of MSO (Figure 3-9A). 
However, when supplemented to glutamine-starved Sp2/0 cultures, MSO had no effect 
on cell viability (Figure 3-9B). The lack of effect of MSO on Sp2/0 cells is not surprising 
as Sp2/0 cells have been shown to express low levels of GS (131,190). 
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A) 
 
 
B) 
 
Figure 3-9 MSO treatment has no effect on cell viability 
A) Ramos cells were deprived of L-glutamine (Gln) for 24 h in the presence or absence 
of MSO. Data are average ± SD of 3 independent experiments. *p<0.05 vs. 
corresponding control cultured in the presence of Gln. +p< 0.05 vs corresponding PBS 
control. B) Sp2/0 cells were deprived of Gln for 3 h in the presence of MSO and 5 mM 
ammonium/ sodium salt or an equivalent volume of PBS. Gln (4 mM) was then added 
and culture was resumed for 24 h. Cell viability was determined by trypan blue 
exclusion. For both panels, cultures in which Gln was added at the start of the 
experiment were included as controls. Data are the average ± SD of 3 independent 
experiments.* p<0.05 vs. corresponding sodium salt-supplemented control.  S. chloride: 
sodium chloride. S. acetate: sodium acetate. A. chloride: ammonium chloride. A. 
acetate: ammonium acetate.  
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3.1.5 Effect of ammonium ions on apoptosis 
3.1.5.1 Cell morphology 
 
I established so far that treatment of glutamine-deprived Sp2/0 cells with ammonium 
ions led to a significant increase in viability. I next asked whether this phenomenon was 
due to an effect of ammonium ions on the apoptotic machinery. To address this, I first 
examined the effect of ammonium salt supplementation on the morphology of 
glutamine-deprived Sp2/0 cells. While the glutamine-starved cells supplemented with 
PBS or the sodium salts showed typical apoptotic features (e.g. smaller cell size, 
apoptotic body formation) treatment with either AA or AC led to a clear increase in the 
number of cells with an apparent normal morphology (Figure 3-10). Thus,  these data 
suggested that ammonium salts interfered with apoptotic processes. 
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Figure 3-10 Ammonium ions improve the morphology of glutamine- starved Sp2/0 
cells. 
Cells were deprived of glutamine (- Gln) for 3 h in the presence of 5 mM 
ammonium/sodium salt or an equivalent volume of PBS. Cultures in which Gln was 
added at the start of the experiment (+ Gln) were included as controls. Magnification:  
400x. S. chloride: sodium chloride. S. acetate: sodium acetate. A. chloride: ammonium 
chloride. A. acetate: ammonium acetate. 
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3.1.5.2 Ammonium ions lower Gln-starved Sp2/0 cell in sub-G phase 
 
One of the hallmarks of apoptosis is cell fragmentation due to the formation of apoptotic 
bodies. The latter can easily be detected by flow cytometry as a sub-G1 peak on DNA 
content frequency histogram. Thus, I used flow cytometry analysis of the DNA content 
of glutamine-starved Sp2/0 cells to confirm the effect of ammonium ions on apoptotic 
processes. Our results showed that the percentage of sub-G1 events in Sp2/0 samples 
deprived of glutamine and supplemented with sodium acetate, sodium chloride or PBS 
was 45.6%, 55% and 56%, respectively (Figure 3-11). The percentage of sub-G1 
events in AC-supplemented cells was not different from the controls, at 44.6%. 
However, the percentage of the sub-G1 event in the glutamine-deprived, AA-treated 
cells was significantly lower, at 34.5%. Altogether, these results suggest that AA, but not 
AC, delayed the progression of apoptosis in glutamine-starved Sp2/0 cells. 
 
3.1.5.3  Detection of Apoptosis using Annexin-V and Propidium Iodide staining 
 
I next examined PS externalization, an apoptotic event which can be easily detected by 
flow cytometry by Annexin-V (AnnV)-FITC staining (191). Co-staining the cells with 
propidium iodide (PI) staining allows the distinction between early apoptotic cells (AnnV 
positive / PI-negative) from late apoptotic cells (AnnV positive/PI positive). 
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Figure 3-11 Ammonium salts lower Sub-G1 Sp2/0 cells. 
A)Sp2/0 cells were cultured with or without glutamine and treated with 5 mM of 
ammonium/sodium salt or an equivalent volume of PBS for 3 hours and analyzed by 
flow cytometry for DNA content as an indication of apoptosis. B) A histogram 
representation of the percentage of non-apoptotic cells in the sub-G1 stage of cell 
cycle. Data are the average ± SD of 3 independent experiments. *p<0.05 vs. PBS. S. 
chloride: sodium chloride. S. acetate: sodium acetate. A. chloride: ammonium chloride. 
A. acetate: ammonium acetate. 
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The results shown in Figure 3-12 and Figure 3-13 clearly indicated that supplementation 
of glutamine-starved Sp2/0 cultures with either AA or AC led to a significant increase in 
the number of viable (AnnV negative/PI negative) cells when compared to the groups 
supplemented with PBS or the corresponding sodium salts. Thus, ammonium ions 
modulate a common marker of apoptosis in glutamine-starved Sp2/0 cells.  
   
 
 
 
Figure 3-12 Ammonium salts improve the viability of glutamine-starved Sp2/0 
cells –flow cytometry assays (AA). 
Cells were deprived of glutamine (Gln) for 3h in the presence of 5 mM 
ammonium/sodium salt or an equivalent volume of PBS. Cells were then processed for 
the determination of cell viability by flow cytometry. A histogram representation of the 
percentage of live and apoptotic cells. Data are the average ± SD of 3 independent 
experiments. . *p<0.05 vs PBS. +p<0.05 vs. corresponding sodium salt-supplemented 
control. S. acetate: sodium acetate. A. acetate: ammonium acetate. Representation of 
raw data is presented in Appendix D. Viable, early/late apoptotic and necrotic cells 
distribution is presented in Appendix C. 
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Figure 3-13 Ammonium salts improve the viability of glutamine-starved Sp2/0 
cells –flow cytometry assays (AC). 
Cells were deprived of glutamine (Gln) for 3h in the presence of 5 mM 
ammonium/sodium salt or an equivalent volume of PBS. Cells were then processed for 
the determination of cell viability by flow cytometry. A histogram representation of the 
percentage of live cells. Data are the average ± SD of 3 independent experiments. 
.*p<0.05 vs PBS.  +p<0.05 vs. corresponding sodium salt-supplemented control. S. 
chloride: sodium chloride. A. chloride: ammonium chloride. Representation of raw data 
is presented in Appendix E. Viable, early/late apoptotic and necrotic cells distribution is 
presented in Appendix C. 
 
 
 
 
3.1.5.4 Ammonium salts do not prevent caspase activation 
 
I next investigated the possibility that ammonium ions interfered with core apoptotic 
processes in glutamine-starved Sp2/0 cells. As a first step, I examined the effect of 
ammonium ions on caspase activation. To this end, Sp2/0 cells were deprived of 
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obtained indicate that, as expected, glutamine starvation led to a significant increase in 
caspase-3 activity over the glutamine-supplemented controls, irrespective of whether 
the cultures were supplemented with PBS or the sodium salts (Figure 3-14D). 
Surprisingly, however, culture supplementation with either AA or AC did not prevent 
caspase-3 activation. This result was confirmed when I examined caspase-3 processing 
from its inactive 33 kDa precursor into its 17 and 19 kDa subunits (Figure 3-14E) and 
found that culture supplementation with ammonium salts did not impede the cleavage of 
procaspase-3 into its active, processed form. Finally, I analyzed the cleavage of a 
number of caspase-3 substrates: poly (ADP-ribose) polymerase (PARP) (Figure 3-14B), 
lamin A/C (Figure 3-14A), as well as DNA fragmentation (Figure 3-14C) (the latter being 
the result of the caspase-3-mediated inactivation of ICAD, an inhibitor of the caspase-
activated DNAse). In all three of these instances, culture supplementation with 
ammonium salts did not prevent cleavage of lamin A/C, PARP nor DNA fragmentation 
(Figure 3-14A/B/C). All in all, these data indicate that the supplementation of glutamine-
starved Sp2/0 cells with ammonium salts, at concentrations that led to a significant 
improvement in cell survival, does not prevent the activation of caspase-3.  
 
 
 
 
 
 
 
  
67 
 
A) 
     
B) 
        
C) 
                     
D)                                                                               E) 
     
Figure 3-14 Ammonium salts do not prevent caspase-3 activation 
Sp2/0 cells were deprived of glutamine for 3h in the presence of 5 mM 
ammonium/sodium salt or an equivalent volume of PBS. A) Cleavage of Lamin. B) 
Cleavage of PARP. C) DNA fragmentation analysis  D) Caspase-3 activity assay. E) 
Western blot shows Caspase-3 processing. Each experiment was performed at least 3 
times.SC: sodium chloride. SA: sodium acetate. AC: ammonium chloride. AA: 
ammonium acetate. In panel A HSP60 was used as a gel loading control, Coomassie 
blue was used for panel B and actin was used as a gel loading control in panel D. 
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3.1.5.4.1 Detection of caspase 3 activity after viable cell purification on Ficoll 
 
The activation of apoptosis in glutamine-deprived Sp2/0 cells is a rapid and 
synchronized event, the majority of the cells showing apoptotic morphological features 
during the second hour of glutamine starvation (131). Thus, one possible reason why I 
could not detect a difference in caspase-3 activity in glutamine-starved Sp2/0 cells upon 
ammonium salt supplementation may be the presence of a significant background of 
apoptotic cells in the culture. To determine if this was the case, I used centrifugation on 
Ficoll to separate dead (denser) cells from live (lighter) cells. Moreover, I decreased the 
time of glutamine starvation from 3h to 2h to reduce the number of cells undergoing 
apoptosis. First, I tested if I can separate live from dead cells in the presence and 
absence of glutamine and then investigate the cleavage of caspase-3 in each fraction.  
As shown in Figure 3-15A, caspase-3 cleavage in the live cell fractions (with or without 
glutamine), was not detected. However, caspase-3 cleavage was present in the dead 
cell fractions confirming a successful separation of live and dead cells. Then I moved to 
test this approach on glutamine-starved Sp2/0 cells. There was no evidence of 
caspase-3 cleavage and activation in the live cells fraction whether the glutamine-
starved cells had been supplemented or not with ammonium salts, PBS or the 
corresponding sodium salts (Figure 3-15B/C).  
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A) 
 
B) 
        
C) 
        
Figure 3-15. Caspase-3 cleavage and cytochrome c release are not due to the 
presence of dead cells in culture (Ficoll treatment) 
Sp2/0 cells were deprived of glutamine (Gln)  for 2 hrs. and then were separated on 
Ficoll gradients 2x to remove all dead cells. Equal protein concentrations were used to 
determine caspase-3 activity and cleavage as well as cytochrome c release by Western 
blot and caspase-3 colorimetric assay.  A) Proof of concept of Ficoll experiment. B) 
Ammonium acetate. C) Ammonium chloride. Each experiment was performed at least 3 
times. Ficoll purified: cells visible at the interface (live cells), control: Ficoll-untreated, 
pellet: Ficoll-purified (dead cells). S. chloride: sodium chloride. S. acetate: sodium 
acetate. A. chloride: ammonium chloride. A. acetate: ammonium acetate. 
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3.1.5.5 Ammonium salts don’t prevent cytosolic release of cytochrome c 
 
When Sp2/0 cells were deprived of glutamine, intrinsic apoptotic pathways are rapidly 
activated. This process involves the permeabilization of the mitochondrial membrane 
and release of cytochrome c, a component of OXPHOS machinery,  from the 
intermembrane space to the cytosol. To examine if the pro-survival effect exerted by 
ammonium ions was due to its interference with this event, Sp2/0 cells were deprived of 
glutamine and supplemented with ammonium salts or corresponding sodium salts for 3 
hours. The cells were then processed for Western blot analysis to detect the release of 
cytochrome c.  As shown in Figure 3-16, ammonium salts did not prevent the release of 
cytochrome c from the mitochondria, indicating that the cytoprotective effect of 
ammonium ions on cell viability is not due to its interference with this event in apoptotic 
machinery. 
 
 
Figure 3-16 Ammonium salts do not interfere with the cytosolic release of 
cytochrome c 
Sp2/0 cells were deprived of glutamine (Gln) for 3h in the presence of 5 mM 
ammonium/ sodium salt or an equivalent volume of PBS then prepared for Western blot 
analysis. SC: sodium chloride. SA: sodium acetate. AC: ammonium chloride. AA: 
ammonium acetate.  Actin was used as a gel loading control. 
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3.1.5.6 Ammonium salts don’t affect BCL-2 proteins levels 
 
Glutamine deprivation modulates the expression of some BCL-2 family members in 
Sp2/0 cells, namely BCL-2, MCL-1, and BAX  (131,160). Therefore, I decided to 
investigate the effect of ammonium salts on the expression of selected BCL-2 family 
members. Sp2/0 cells were deprived of glutamine and supplemented with ammonium 
salts or corresponding sodium salts for 3 hours. The cells were then processed for 
Western blot analysis to detect the expression levels of a number of BCL-2 family 
members.  Figure 3-17  shows that ammonium salts had no impact on the level of 
expression of the investigated BCL-2 family members, indicating that the cytoprotective 
effect of ammonium ions is not due to its interference with the expression of these 
important proteins in the apoptotic machinery. 
 
 
3.1.5.7  Ammonium salts decrease apoptotic nuclei in glutamine-starved Sp2/0 
cells 
 
Having established that ammonium ions improved cell viability upon glutamine 
starvation without affecting the core apoptotic machinery, I turned my attention to 
nuclear condensation and fragmentation, two late apoptotic events which are known to 
occur in Sp2/0 cells deprived of glutamine (131). To achieve this, Sp2/0 cells were 
deprived of glutamine and supplemented with ammonium salts (or the corresponding 
sodium salt) for 3 hours. Nuclear morphology was then examined by Hoechst staining 
and fluorescence microscopy. 
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A) 
 
 
 
 
B) 
 
 
 
Figure 3-17 Ammonium ions do not interfere with BCL-2 proteins 
Sp2/0 cells were deprived of glutamine for 3h in the presence of 5 mM ammonium/ 
sodium salt or an equivalent volume of PBS. A) Effect of AA on Bcl-2 proteins. B) 
Effect of AC on Bcl-2 proteins SC: sodium chloride. SA: sodium acetate. AC: 
ammonium chloride. AA: ammonium acetate. In panel A,  Actin was used as a gel 
loading control. Figure provided by Catherine Zhou. 
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 As shown in Figure 3-18A, the number of cells containing apoptotic nuclear 
condensation and fragmentation was significantly lower when cells were treated with 
ammonium salts compared to sodium salts or PBS controls. Upon enumeration, I found 
that both AA and AC led to a significant decrease in the number of cells with apoptotic 
nuclei compared to the controls (Figure 3-18B). All together, these experiments suggest 
that ammonium ions modulate the viability of glutamine-starved Sp2/0 cells in part by 
affecting late apoptotic events.  
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A) 
    
B) 
 
Figure 3-18 Ammonium ions lower apoptotic nuclei in glutamine-deprived Sp2/0 
cells 
Sp2/0 cells were deprived of glutamine (Gln) for 3h in the presence of 5 mM 
ammonium/sodium salt or an equivalent volume of PBS. Hoechst 33342 was added to 
the cultures 30 min before the end of the experiment. The cells were then processed 
for fluorescence microscopy. A) Fluorescence microphotographs (magnification: 
400x). B) Enumeration of cells showing apoptotic nuclear condensation/fragmentation. 
At least 200 nuclei were enumerated for each group. Data are the average ± SD of 3 
independent experiments. *p<0.05 vs. PBS-supplemented control. +<0.05 vs. 
corresponding sodium salt-supplemented control. S. chloride: sodium chloride. S. 
acetate: sodium acetate. A. chloride: ammonium chloride. A. acetate: ammonium 
acetate. 
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3.2 Glutamine analogs and ammonium ions 
 
In this section, I analyzed two glutamine analogs, DON and AZA, for their effect on 
Sp2/0 cells. Glutamine analogs compete with glutamine and block glutamine-
metabolizing enzymes by irreversibly binding to them. I wished to examine if the 
increased viability of Sp2/0 cells upon supplementation with ammonium ions involved 
the glutamine-metabolizing enzymes and see if combining glutamine analogs with 
ammonium ions would interfere with the latter’s ability to improve the survival of 
glutamine-starved Sp2/0 cells.  
 
3.2.1 Treating glutamine-deprived Sp2/0 cells with ammonium salts and a 
glutamine analogue significantly improves cell survival 
 
Considering that glutamine analogs triggered Sp2/0 cells death in the presence of 
glutamine (Figure 3-4), I wondered whether DON or AZA would potentiate the cell death 
signal triggered by glutamine starvation. A dose response experiment to investigate the 
effect of  different concentraions of DON and AZA was performed to determine the 
optimum concentration with reduced cell death in glutamine supplemented Sp2/0 cells 
(Appendix B). Therefore, Sp2/0 cells were deprived of glutamine for 3 h, in the presence 
of either DON or AZA. Cells to which PBS was added were used as controls. To our 
surprise, both glutamine analogs led to an increase in Sp2/0 cell viability upon 
glutamine starvation (Figure 3-19). These results prompted us to investigate whether 
the combination of glutamine analogs and ammonium ions could lead to a greater 
increase in the viability of glutamine-starved Sp2/0 cells.  Sp2/0 cells were deprived of 
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glutamine for 3h in the presence of ammonium salts and either DON or AZA. As 
controls, cells supplemented with PBS or the corresponding sodium salts were also 
used. Interestingly,  culture supplementation with the combination of AA or AC and DON 
led to significantly higher cell viability, to approximately 75% and 70%, respectively, 
compared to the PBS-treated group (Figure 3-19A). Of note, the combination of SA or 
SC with DON also caused a significant increase in cell viability by approximately 50% 
compared to 30% in PBS group. Sp2/0 cells deprived of glutamine and supplemented 
with either AA or AC with AZA also showed a significant increase in viability 
(Figure 3-19B).  Interestingly, for both glutamine analogs, AC was less potent at 
increasing the viability of glutamine-starved Sp2/0 cells compared to AA (Figure 3-19). 
These results indicate that the combination of ammonium salts and glutamine analogs 
were able to significantly protect the glutamine-starved Sp2/0 cells against cell death. 
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A) 
 
B) 
 
Figure 3-19 Combination of ammonium salts and DON/AZA protect glutamine-
deprived Sp2/0 cells  
Cells were deprived of glutamine (Gln) (black bars) for 3h in the presence of 5 mM 
ammonium /sodium salt or an equivalent volume of PBS. One µM of DON (Panel A) or 
2µM of AZA (panel B) were added at the start of the experiment. After 3 h, cells were 
washed 2X with fresh IMDM then Gln (4 mM) was then added and culture was resumed 
for 24 h. Cell viability was determined by trypan blue exclusion. In all controls, Gln was 
added at the start of the experiment. Data are the average ± SD of 3 independent 
experiments. *p<0.01 vs. PBS. ŧp<0.05 vs. DON or AZA. +p<0.05 vs corresponding 
sodium salt- supplemented control/DON/AZA. S. chloride: sodium chloride. S. acetate: 
sodium acetate. A. chloride: ammonium chloride. A. acetate: ammonium acetate. 
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To confirm these results, I performed a clonogenic assay. Sp2/0 cells were deprived of 
glutamine for 3 h in the presence of a glutamine analog and an ammonium salt. The 
cells were then processed for a clonogenic assay, as described in the Materials and 
Methods section 2.2.4. As shown in Figure 3-20, glutamine-starved cells treated with 
DON or AZA alone showed an increase in colony formation compared to the control, 
confirming the results shown in Figure 3-19. Moreover, the co-treatment of glutamine-
deprived cells with AA or AC and DON led to a significant increase in the number of 
colonies over the sodium salt control. Similar results were obtained when AZA was used 
as a glutamine analog. Importantly, the increase in colony formation was greater when 
the combination of glutamine analog/ ammonium salt was used than when the 
ammonium salts were used alone. All together, these results clearly indicate that the 
combination of a glutamine analog and an ammonium salt results in a much greater 
preservation of proliferative capacity when Sp2/0 cells are deprived of glutamine.  
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A) 
 
B) 
 
Figure 3-20 Combination of ammonium salts and DON/AZA increase proliferation 
of  glutamine-deprived Sp2/0 cells in clonogenic assay  
Cells were deprived of glutamine (Gln) for 3h in the presence of 5 mM 
ammonium/sodium salt or an equivalent volume of PBS. One µM of DON or 2µM of 
AZA were added at the start of the experiment. Cells were then processed for 
clonogenic assay. Briefly, cells were cultured at a cell density of 0.5 cells/well in 96 well 
plate cultured in IMDM + 4 mM Gln. After 7-10 days, colonies over ~50 cells per well 
were counted. Data are the average ± SD of 3 independent experiments. *p<0.01 vs. 
PBS. ŧp<0.05 vs. DON or AZA. +p<0.05 vs corresponding sodium salt- supplemented 
control/DON/AZA. A) DON. B) AZA. S. chloride: sodium chloride. S. acetate: sodium 
acetate. A. chloride: ammonium chloride. A. acetate: ammonium acetate. 
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3.2.2 The combination of glutamine analogs and ammonium salts impedes the 
apoptotic process 
3.2.2.1 Cell morphology 
 
I next sought to determine whether the combination of glutamine analog and ammonium 
salt interfered with the induction of apoptosis in glutamine-starved Sp2/0 cells.  When 
cells were examined by light microscopy, it was apparent that the use of glutamine 
analogs alone did not have a significant impact on morphology, with the glutamine-
deprived cells showing typical signs of apoptosis (shrinkage, cell fragmentation, 
apoptotic body formation) (Figure 3-21). On the other hand, co-treatment of glutamine-
starved Sp2/0 cells with ammonium salts and DON led to a cell morphology that 
resembled that of the controls supplemented with glutamine (Figure 3-21A). Similar 
results were obtained when glutamine deprived Sp2/0 cells were co-treated with 
ammonium salts and AZA (Figure 3-21B). Thus, these data suggest that the 
combination of a glutamine analog and ammonium salts is effective in inhibiting 
apoptosis. 
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A) 
 
B) 
 
Figure 3-21 Combination of ammonium salts and DON/AZA improve cell 
morphology 
Cells were deprived of glutamine (- Gln) for 3 h in the presence of 5 mM 
ammonium/sodium salt or an equivalent volume of PBS. One µM of DON or 2µM of 
AZA were added at the start of the experiment Cultures in which Gln was added at the 
start of the experiment (+ Gln) were included as controls. A) DON. B) AZA. Each 
experiment was repeated at least 3 times. Magnification: 400x. S. chloride: sodium 
chloride. S. acetate: sodium acetate. A. chloride: ammonium chloride. A. acetate: 
ammonium acetate. 
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3.2.2.2 Phosphatidylserine externalization 
 
To confirm that the combination of a glutamine analog and ammonium salts was 
effective in inhibiting apoptosis in Gln-starved Sp2/0 cells, I used the AnnV-PI assay. 
This assay allows one to determine if phosphatidylserine externalization, a phenomenon 
typical of apoptotic cells, had occurred. I already showed that treatment of Sp2/0 cells 
with either DON or AZA in the presence of glutamine leads to approximately 80% death 
(Figure 3-4 and 3-5). I also showed that this effect was partially negated by the 
supplementation with ammonium salts (Figure 3-5). To investigate if this phenomenon 
involved the inhibition of apoptosis, I used the Annexin V / Propidium iodide (AnnV-PI) 
assay. A significant decrease in the number of viable (AnnV negative / PI negative) cells 
was observed when Sp2/0 cells were exposed to either DON or AZA (Figure 3-22). 
Interestingly, the addition of ammonium salts led to a significant increase in the number 
of viable cells. Thus, this confirms that ammonium salts impede the induction of 
apoptosis by these analogs, even in the presence of glutamine. 
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A) 
 
B) 
 
Figure 3-22 Combination of ammonium salts and DON/AZA in the presence of 
glutamine reduce Annexin-V externalization and PI uptake. 
Cells were cultured with glutamine for 24h in the presence of 5 mM ammonium/sodium 
salt or an equivalent volume of PBS. One µM of DON or 2µM of AZA were added at the 
start of the experiment. Cell viability was determined by flow cytometry. Data are the 
average ± SD of independent experiments. *p<0.05 vs. DON or AZA. +p<0.05 vs 
corresponding sodium salt- supplemented control. DON: 6-Diazo-5-oxo-L-norleucine, 
AZA: azaserine, S. chloride: sodium chloride. S. acetate: sodium acetate. A. chloride: 
ammonium chloride. A. acetate: ammonium acetate. 
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 To confirm whether the combination of glutamine analog and ammonium salts inhibited 
apoptosis in Glutamine-starved cells, I used the AnnV-PI assay. Sp2/0 cell cultures 
deprived of glutamine and supplemented with DON or AZA showed a significant 
increase in the number of viable cells, as indicated by AnnV/PI staining. Moreover, 
when cell cultures were supplemented with either DON or AZA in the presence of either 
AA or AC, a larger increase in the number of viable cells was observed (Figure 3-23). 
Therefore, these results confirm that a combination of glutamine analog with ammonium 
did indeed interfere with apoptotic processes in glutamine-deprived Sp2/0 cells. 
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A) 
 
B) 
 
Figure 3-23 Treatment with ammonium salts in combination with DON or AZA 
improves cell viability. 
Cells were deprived of glutamine for 3h in the presence of 5 mM ammonium/sodium 
salt or an equivalent volume of PBS. One µM of DON or 2µM of AZA were added at the 
start of the experiment Cells were then processed for the determination of cell viability 
by flow cytometry. Cultures in which Gln was added at the start of the experiment were 
included as controls. A) Ammonium acetate. B) Ammonium chloride. Data are the 
average ± SD of 3 independent experiments.*p<0.05 vs. PBS. ŧp<0.05 vs DON or AZA. 
+p<0.05 vs corresponding sodium salt-supplemented control. S. chloride: sodium 
chloride. S. acetate: sodium acetate. A. chloride: ammonium chloride. A. acetate: 
ammonium acetate. 
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3.2.2.3 Caspase-3 activation  
The significant improvement in cell viability upon supplementation of ammonium ions 
and glutamine analogs, led us to investigate their effect on the activation of caspase-3. 
To achieve this, Sp2/0 cells were deprived of glutamine and supplemented with DON or 
AZA and with either AA, AC, PBS, or corresponding sodium salt for 3h. Then a 
caspase-3 colorimetric activity assay was performed.  As shown in Figure 3-24A, a 
significant reduction in caspase-3 activation was observed when cells were co-
supplemented with DON and either AA or AC when compared to PBS or corresponding 
sodium salts.  These results were confirmed when I investigated the processing of the 
inactive form of caspase-3 to an active form by Western blotting (Figure 3-24B). As 
expected, glutamine deprivation caused the cleavage of the 32 kDa pro-caspase-3 to its 
active form. Importantly, supplementation with DON and either AA or AC caused a 
reduction in caspase-3 processing and lamin cleavage (Figure 3-24).  Of note, a lower 
reduction in the processing of caspase-3 or lamin cleavage was observed when cells 
were supplemented with DON in the presence of AC than with AA. Similar results were 
obtained when glutamine deprived Sp2/0 cells treated with AZA and either AA or AC. 
The co-treatment lowered the activation of caspase-3 but not the cleavage  
(Figure 3-25A/B) as well as the cleavage of lamin (Figure 3-25C). Similar to my 
observations with DON, reduction of caspase-3 activation was more pronounced when 
the mixture of AZA and AA was used. Therefore, these results show that that co-
supplementation of glutamine analog with ammonium salts to glutamine-deprived cells 
can significantly interfere with apoptosis machinery, at least in part, by limiting the 
activation of caspase-3. 
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A) 
        
B) 
     
C) 
 
 
Figure 3-24 Combination of ammonium salts and DON inhibits caspase-3 or lamin 
cleavage 
Sp2/0 cells were deprived of glutamine (Gln) for 3h in the presence of 5 mM 
ammonium/sodium salt or an equivalent volume of PBS. One µM of DON was added at 
the start of the experiment A) Caspase-3 activity assay. Data are the average ± SD of 3 
independent experiments. *p<0.05 vs. PBS. ŧp<0.05 vs DON. +p<0.05 vs. 
corresponding sodium salt-supplemented control. B) Western blot shows Caspase-3 
processing, full-length and the cleaved forms, respectively. C) Cleavage of Lamin. SC: 
sodium chloride. SA: sodium acetate. AC: ammonium chloride. AA: ammonium acetate. 
HSP60 and Actin were used as gel loading controls. Densitometry of Western blot 
bands (B and C) is presented in Appendix F. 
 
0
0.05
0.1
0.15
0.2
0.25
0.3
PBS DON S. acetate A. acetate S. chloride A. chloride
A
b
so
rb
an
ce
 +Gln   -Gln
DON
*
*
ŧ
ŧ
†
+
  
88 
 
A) 
          
B) 
   
C) 
 
Figure 3-25 Combination of ammonium salts and AZA inhibits caspase-3 or lamin 
cleavage 
Sp2/0 cells were deprived of glutamine (Gln) for 3h in the presence of 5 mM 
ammonium/sodium salt or an equivalent volume of PBS. Two µM of AZA were added at 
the start of the experiment A) Caspase-3 activity assay. Data are the average ± SD of 3 
independent experiments. .*p<0.05 vs PBS. ŧp<0.05 AZA. +p<0.05 vs. corresponding 
sodium salt-supplemented control. B) Western blot shows Caspase-3 processing, full-
length and the cleaved forms, respectively. C) Cleavage of Lamin. SC: sodium chloride. 
SA: sodium acetate. AC: ammonium chloride. AA: ammonium acetate. HSP60 and 
Actin were used as gel loading controls. Densitometry of Western blot bands (B and C) 
is presented in Appendix G. 
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4. DISCUSSION  
 
The better we understand the molecular mechanisms of cancer initiation and 
development, the more new avenues will be available for developing new treatments for 
this disease and improve its prognosis and survival.  The metabolic reprogramming that 
is specific for proliferating and cancer cells is a very attractive strategy to develop 
anticancer drugs (192). In that regard, the dependence of cancer cells on glutamine for 
their growth and proliferation is of particular interest (32,51,54,193). While the 
importance of glutamine for cell viability has been known for decades (194), the 
molecular mechanisms underlying this phenomenon are still largely unclear.   
 
In this thesis, I investigated the effect of ammonium ions, a by-product of glutamine 
metabolism, on the induction of apoptosis in glutamine-deprived Sp2/0 cells. My data 
showed that ammonium ions significantly improved cell viability, PS externalization and 
nuclear condensation of glutamine-deprived Sp2/0 cells. The promotion of cell survival 
by ammonium ions occurred without reducing the activation of caspase-3 nor the 
release of cytochrome c in glutamine-starved Sp2/0 cells. The improvement of the 
viability of glutamine-deprived Sp2/0 cells upon exposure to ammonium ions despite the 
activation of caspase 3 is puzzling. However, caspase 3 activation itself does not 
necessarily lead to cell death. For instance, caspase 3 activation (in the absence of 
apoptosis) was found to be involved in the differentiation of different types of cells 
including muscle cells, monocytes, erythroid cells and embryonic stem cells as well as 
regulation of cell cycle in B cells (195-200). The mechanisms by which cells evade 
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apoptosis while caspase-3 is activated, are still poorly understood (196,201,202). Cells 
can counterbalance the progression of apoptosis upon caspase activation by 
upregulating the expression of antiapoptotic proteins such as IAPs and BCL-2 proteins 
or activate pro-survival pathways (202). It was reported that caspase-3 could be 
activated in healthy cells in order to circumvent mild stress through activation of anti-
apoptotic AKT kinase upon partial cleavage of RasGAP by caspase 3 (196,203-205). 
Caspase 3 was also found to be essential for neuroprotection after preconditioning, a 
phenomenon which required HSP70 expression (206). 
 
4.1 Potential mechanisms for the modulation of cell survival by 
ammonium ions in glutamine-deprived Sp2/0 
 
Recently, emerging roles of ammonia in the modulation of cell viability were uncovered 
(207-210).  
 
4.1.1 Heme oxygenase-1 
Heme oxygenase-1 (HO-1) is an enzyme that catabolizes heme to generate iron, 
carbon monoxide (CO) and biliverdin. The latter is subsequently catabolized by 
biliverdin reductase into bilirubin. HO-1 was reported to promote the viability and 
function of endothelial cells (207,211,212) Researchers also showed that ammonia 
induces HO-1 expression (213) and recently it was reported that HO-1 promotes 
endothelial cell survival by regulating cellular prooxidant iron and production of carbon 
monoxide (CO) which are potent antiapoptotic factors (207,209,214). Endothelial cells 
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produce high rates of ammonia through glutamine catabolism through glutaminase 
activity (215). Whether HO-1 modulates the survival of Sp2/0 cells and is a target of 
ammonium ions in this cell line remains to be determined.  
 
4.1.2 Contribution of autophagy 
A number of studies have uncovered a possible link between glutamine metabolism and 
autophagy, a cell response usually associated with the promotion of survival (216). 
Jardon et al. recently reported that glutamine deprivation stimulates autophagy (217). In 
contrast, glutamoptosis is a new form of cell death characterized by the ability of 
glutaminolysis to inhibit autophagy via its activation of mTORC-1 (218,219). In cells 
undergoing glutamoptosis, conditions of nutrient limitation (i.e. with only glutamine and 
leucine provided as amino acids) trigger the inhibition of autophagy, resulting in the 
activation of caspase-8-dependent apoptosis (218,219).  
 
Interestingly, it was recently reported that ammonium ions play several roles in 
regulating autophagy. Eng et al. reported that ammonium ions decreased TNF-α-
induced cell death and that was due to an increased level of autophagy (161).  
Moreover, ammonium ions have been shown to stimulate mTORC2 and mTORC1 in a 
dose-depended manner: ammonium ions activate mTORC2 through the release of 
stored calcium from endoplasmic reticulum and mTORC1 through stimulation of AKT-
dependent inhibition of two mTORC1 negative regulators, TSC complex and PRAS40 
(220). 
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A link between glutaminolysis (and ammonium ions) and autophagy is interesting 
considering that a high rate of autophagy is detected in some types of cancer (221,222). 
For example, it was reported that the constitutively high level of autophagy in lung 
adenocarcinoma cells enables them to survive in a low-oxygen or nutrient-restricted 
environments. Furthermore, when autophagy was inhibited, viability of these cells was 
decreased (223). Interestingly, autophagy was found to be under the control of c-Myc, a 
decrease in c-Myc protein levels was recently correlated with a reduction in autophagy 
(224,225). In rapidly proliferating and cancer cells, c-Myc is known to reprogram 
metabolic pathways and that change leads these cells to be more dependent on 
glutamine. Therefore, induction of autophagy, in this case, would provide the necessary 
components for cell survival and proliferation. Thus, increased autophagic flux upon 
supplementation of ammonium ions to Sp2/0 cells cultured in glutamine-free media 
could promote their survival.  
 
Several attempts were made to measure autophagy in glutamine-deprived Sp2/0 cells 
supplemented with ammonium ions. However, I faced several difficulties. Using 
Western blot analysis to detect LC3-I and LC3-II (two biochemical markers of 
autophagy) in Sp2/0 cells proved to be unreliable, as the signal was very weak and 
inconsistent. This prompted me to attempt the transfection of Sp2/0 cells with GFP-
tagged proteins commonly used as markers for autophagy. While the transfection 
(stable or transient) of Sp2/0 cells with a GFP-expressing vector worked, transfecting 
the cells with a LC3-GFP fusion protein (to detect the formation of autophagosomes) 
was unsuccessful: the ectopic expression of LC3-GFP was toxic to Sp2/0 cells. I also 
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attempted to transfect Sp2/0 cells with a WIPI1-GFP fusion protein (WIPI-1 accumulates 
at the phagophore of cells undergoing autophagy (226-228).  Here again, I was 
unsuccessful at expressing the fusion protein, probably due to its toxicity in Sp2/0 cells. 
It should be mentioned that, in previous studies performed in our laboratory, it was 
observed that Sp2/0 cells undergo apoptosis upon exposure to nanomolar amounts of 
the autophagy inhibitor bafilomycin A1 (183).  The difficulty in studying autophagy in 
Sp2/0 cells may be an indication that this process is critical to the survival of this cell 
line, and that small disturbances in the autophagy process are sufficient to trigger a cell 
death response. More studies are required to test this possibility.   
 
Qiang et. al., have recently reported that p38 activation is controlled by autophagy to 
promote cell survival during genotoxic stress (229). They showed that in cells that were 
sensitized to autophagy deficiency, UVB-induced apoptosis is triggered as a result of 
p62-mediated p38 activation. They also showed that in squamous cell carcinoma, 
autophagy was activated and that was in correlation with decreased activation of p38. 
Furthermore, they concluded that autophagy promotes cell survival by suppressing p62-
mediated p38 activation (229). Studies performed in our laboratory have shown that in 
glutamine deprived Sp2/0 cells, the p38 kinase is activated and that this activation leads 
to induction of typical morphological late apoptotic features such as nuclear 
condensation and fragmentation as well as cell membrane blebbing (140). Moreover, 
while the inhibition of p38 did not prevent caspase activation in glutamine-starved Sp2/0 
cells, it reduced the extent of nuclear condensation/fragmentation and cell membrane 
blebbing. Our research group also showed that the activation of p38 in glutamine-
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deprived Sp2/0 cells was in response to oxidative stress. Therefore, the lower nuclear 
condensation and cell membrane blebbing observed upon ammonium ions treatment of 
glutamine-starved Sp2/0 cells might be due to increased levels of ammonia-derived 
autophagy and hence lower levels of p38 activation. The possible involvement of p38 in 
the pro-survival response triggered by ammonium ions could be tested through the use 
of chemical inhibitors (e.g. SB 203580) or the transfection of Sp2/0 cells with dominant-
negative versions of the p38 kinase (140).  
 
The potential contribution of autophagy to the modulation of the survival of glutamine-
starved Sp2/0 cells could be determined using alternative approaches. For instance, 
autophagy inhibitors such bafilomycin A1 or 3-methyl adenine could be used. As stated 
earlier, care should be taken when using these chemicals, as they both quite toxic to 
Sp2/0 cells (183). Alternatively, altering key components of the autophagic pathways 
(e.g. beclin-1) through RNA interference or ectopic expression approaches could 
provide us with useful information as to the contribution of this phenomenon to the effect 
of ammonium ions on Sp2/0 cells. Using flow cytometry as a method of measuring the 
levels of autophagy is also very promising to be useful in Sp2/0 cells (230). For 
example, flow cytometry can be used to measure different aspects of autophagy such 
as LC3 (autophagosome) accumulation, its upregulation throughout cell cycle, and co-
localization of autophagosomes and lysosomes (231,232). 
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4.1.3 GADD-153 
The stress-related transcription factor GADD-153 was reported to be up-regulated 
under hyperammonemic conditions (233). Moreover, GADD-153 levels were shown to 
be increased following the inhibition of autophagy (234). Interestingly, this transcription 
factor was shown to be up-regulated in glutamine-starved Sp2/0 cells (235). It was 
reported that upregulation of GADD-153 leads to increased expression of mitochondrial 
chaperone proteins which provide the mitochondria with the capability to cope with the 
accumulation of unfolded proteins. Therefore, it would be interesting to measure the 
expression levels of GADD-153 in glutamine-deprived Sp2/0 cells supplemented with 
ammonium ions or knockdown GADD-153 gene by small-interfering RNA and see if the 
protective effect of ammonium ions still occurs.  
 
4.1.4 Contribution of acetate and ketoglutarate to the effect of ammonium ions  
While both ammonium acetate and ammonium chloride increased cell viability, I noticed 
that ammonium acetate exerted a greater level of protection compared to ammonium 
chloride. Therefore, I asked if this increase in viability due to carbon source provided by 
the presence of acetate. This was investigated by treating glutamine-deprived Sp2/0 
cells with methyl pyruvate (MPyr), as a replacement for acetate, in combination with 
ammonium chloride. The addition of MPyr did not improve in the effect of ammonium 
chloride on cell viability. Similar results were obtained when the amino acid glutamate 
was used along with ammonium chloride (Figure 3-7).  
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The role of acetate in promoting cell survival is not clear but it may be due to its 
conversion into acetyl-CoA via acetyl-CoA synthetase (ACSS2) (236,237) Acetyl-CoA 
can then be metabolized in the TCA cycle or used by the cell for biosynthesis of lipids. 
Acetyl-CoA can also act as a substrate for the synthesis of UDP-GlcNAc which can, in 
turn, promote cell viability (238). Therefore, in rapidly proliferating cells such as Sp2/0 
cells, it is possible that acetate has a protective role in the absence of glutamine. 
Another explanation of the weaker effect of ammonium chloride in comparison to 
ammonium acetate is that ammonium chloride has been shown to induce a transitory 
increase in mitochondrial pH which in turn leads to an increase in production of ROS 
(239-243). Measuring intracellular level of ammonia or use of ROS scavengers might 
shed some light on this possibility.  
 
Supplementation of α-ketoglutarate, another metabolite derived from glutaminolysis, 
also led to a significant increase in cell viability when added to glutamine-deprived 
Sp2/0 cells. This suggests that glutamine protection against cell death may be due to 
other metabolites of glutamine besides ammonia. This can be attributed to the effect of 
α-ketoglutarate on mTORC1 signaling pathway, which is responsive to nutrient 
starvation and links cell metabolism to autophagy. This, in turn, has been shown to 
influence cell survival (152,244,245). Ammonium ions can also activate mTORC1 
pathway, which is usually inhibited in cancer cells due to nutrient stress (216). mTORC1 
activation promotes α-ketoglutarate production through activation of glutamate 
dehydrogenase (152) and hence production of ammonia and stimulation of autophagy. 
Moreover, as α-ketoglutarate is known to activate the mTOR pathway, the result of this 
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interplay would be a feedback loop for constitutive stimulation of autophagy (246). The 
role of mTOR in Sp2/0 cells could be examined by inhibiting mTOR in the presence of 
ammonium ions or α-ketoglutarate. However, it was reported that ammonium ions 
promote autophagy independently of ULK1/ULK2 kinases, two protein kinases involved 
in autophagosome formation and subject to modulation by mTOR (247). Therefore, 
combined treatment with ammonium ions and rapamycin, an mTOR-dependent 
autophagy stimulator, could further elucidate the effect of ammonium ions on cell 
viability in glutamine-starved Sp2/0 cells. Nevertheless, no additive effect on cell viability 
was observed when glutamine-starved cells were treated with a combination of α-
ketoglutarate and ammonium ions (Figure 3-8). This finding is in contrast to the results 
reported by Eng et al., (161) where a synergetic effect of ammonium ions and α-
ketoglutarate was observed. This is possibly the result of the fact that I had to use lower 
amounts of dimethyl--ketoglutarate in our experiments, as this chemical proved toxic to 
Sp2/0 cells (results not shown).  
 
Finally, another way ammonia can contribute to cell survival is by its effect on 
glutathione levels. It was reported that ammonia increases the antioxidant, glutathione 
levels to 80% in cerebral cortical microdialysates and was also able to increase 
glutathione synthesis in cerebral cortical astrocytes and a C6 glioma cell line (248). It 
was also reported by others that supplementation of ammonia to hybridoma cells 
increases the activity of glutamate dehydrogenase leading to glutamine synthesis from 
ammonia and α-ketoglutarate (187). However, improvement in cell viability upon 
treatment with ammonium ions was not attributed to an increase in glutamine production 
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by glutamine synthetase (GS), since treating glutamine-deprived Sp2/0 cells with 
methionine sulfoximine did not prevent ammonium ions from improving cell viability on 
cell viability (Figure 3-9).  
 
4.2 Effect of ammonium ions on intrinsic apoptotic pathway 
After confirming the increased cell viability induced by ammonia treatment on glutamine-
starved Sp2/0 cells, I started to study the effect of ammonia on key components of the 
intrinsic apoptotic pathway. Ammonium ions supplementation did reduce PS 
externalization, the number of cell in the sub-G1 phase in cell cycle and nuclear 
condensation/fragmentation in glutamine-starved Sp2/0 cells (Figures 3-9, 3-10 and 3-
15). This indicates that ammonium ions interfered with the progress of the apoptotic 
process.  
 
Ammonia has been shown to affect the size of the nucleus in a caspase-independent 
manner and increases the activity of phospholipase A2 (PLA2), an enzyme involved in 
nuclear shrinkage (249-251). This might explain the effect of ammonium ions on nuclear 
condensation and the null effect on the core components of apoptosis. It would be 
interesting to know if PLA2 is at play in glutamine-deprived/ammonium ion 
supplemented Sp2/0. This can be confirmed by using selective intracellular PLA2 
activity inhibitors such as methyl arachidonyl fluorophosphonate (MAFP), bromoenol 
lactone (BEL), and arachidonyltrifluoromethyl ketone (AACOCF3) (249) and examine 
whether nuclear shrinkage still occurs.  
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Ammonium ions were also shown by others to increase the intracellular pool of UDP-
GlcNAc, involved in protein O-glycosylation, a post-translational modification known to 
inhibit cell death (238,252). O-GlcNAc is involved in the modification of PFK1, an 
enzyme involved in glycolysis, leading to increased rates of glucose entry into the 
pentose phosphate pathway, instead of the TCA cycle, to promote growth and survival 
in rapidly proliferating cells such as cancer  (253,254)  O-GlcNAc is involved in 
autophagy through the regulation of lysosomal protein degradation and this regulation 
depends on the conditions of nutrients availability (255). O-GlcNAc also activates AMPK 
and the latter is involved in cell survival against stress (256). O-GlcNAc also promotes 
the expression levels of HIF-1α and attenuate the activation of unfolded protein 
response to ER stress (257). It was also reported that UDP-GlcNAc protein is necessary 
for proliferation and adhesiveness of mouse embryonic fibroblasts (MEFs) deficient for 
EMeg32 which can be recovered by nutritional restoration of intracellular UDP-GlcNAc 
levels (258). In addition, different proteins in the cell are also targets for O-
GlcNAcylation such as nuclear pore proteins, transcription factors, as well as chromatin-
modifying enzymes (253,259,260). Therefore, detection of intracellular levels of UDP-
GlcNAc in glutamine-starved/ammonium ion supplemented Sp2/0 cells would provide a 
good indication if UDP-GlcNAc has a role in the observed increased cell viability. 
 
Our data showed that supplementation with ammonium salts had no impact on the core 
intrinsic apoptotic events such as cytochrome c release, BCL-2 family protein levels, 
caspase-3 activation, PARP, and Lamin A/C cleavage. The apparent lack of effect of 
ammonium ions on intrinsic apoptotic pathways in glutamine-starved Sp2/0 cells may be 
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due to the fact that ammonia was reported by others to actually induce intrinsic 
apoptosis via blocking complexes I-IV of the mitochondrial respiratory chain, leading to 
depolarization of mitochondrial membrane and hence the release of cytochrome c to the 
cytosol (261-263). It is difficult, however, to reconcile these events with the long-term 
protection afforded by ammonium ions in glutamine-starved Sp2/0 cells, and the fact 
that ammonium ions, on their own, did not trigger apoptosis in glutamine-supplemented 
Sp2/0 cells.  
4.3 Ammonium ions and glutamine analogs 
Next, I reported on the effect of glutamine analogs on the viability of Sp2/0 cells. 
Treating Sp2/0 cells with either DON or AZA was highly toxic to the cells, even in the 
presence of glutamine. This indicates that interfering with glutamine catabolism is 
sufficient to trigger Sp2/0 cell death. Treatment of Sp2/0 cells with either DON or AZA in 
the presence of glutamine in combination with either ammonium acetate or ammonium 
chloride afforded some protection from apoptosis compared to control groups 
(Figure 3-5).  
 
Surprisingly, the viability of glutamine-deprived Sp2/0 cells treated with a glutamine 
analog and an ammonium salt was considerably improved (Figure 3-19). These results 
were supported by several complementary experiments: clonogenic assays, flow 
cytometry analysis, examination of cell morphology, as well as biochemical assays 
(caspase activity, Western blot analysis).  However, the reasons behind the lower 
cleavage and activation of caspase-3 proteins are not entirely clear.  
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Although I only showed the effect of combined treatment of glutamine-starved Sp2/0 
cells with ammonium ions and glutamine analogs on caspase-3, it would be interesting 
to investigate the effect of ammonium ions on other core apoptotic machinery such as 
the cytosolic release of cytochrome c, the modulation of BCL2 family proteins, and the 
requirement for other caspases. Detection of cytochrome c release through Western 
blotting upon supplementation of ammonium ions to glutamine-starved Sp2/0 cells as 
well as the examination of the levels of BAX and BAK in the cytoplasm or their 
activation and translocation to the mitochondria would show that ammonium ions and 
glutamine analogs work upstream of the permeabilization of the outer mitochondrial 
membrane. If cytochrome c is still released, however, that means ammonium ions and 
glutamine analog might interfere with the processes responsible for the activation of 
caspase-3. 
 
Both ammonium ions and DON have been shown to affect the synthesis of UDP-
GlcNAc and O-GlcNAc, the levels of which are linked to apoptosis (78).  Glutamine 
analogs, DON and AZA, decrease O-GlcNAc levels by blocking glutamine-fructose-6-
phosphate transaminase (GFAT), the rate-limiting enzyme of the hexosamine 
biosynthetic pathway (HBP) which uses glutamine as an amino group donor (264). 
However, ammonium ions stimulate the O-GlcNAc-modification of proteins. As both, 
glutamine analog and ammonium ions affect the levels of O-GlcNAc, suggests an 
interplay between glutamine analogs and ammonium ions via protein modification by O-
GlcNAc to promote survival of glutamine-starved Sp2/0 cells. This can be confirmed by 
using RNA interference against O-GlcNAc or by using pharmacological inhibitors such 
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as O-(2-acetamido-2-deoxy-D-glucopyrano-sylidene)amino-N-phenylcarbamate 
(PUGNAc) (265) along with detection of protein modification by O-GlcNAc by Western 
blotting using anti-O-GlcNAc antibodies during ammonium ions and DON or AZA 
treatment. 
 
Apoptosis is a process of events that requires energy. Amongst these events are 
blebbing, the formation of apoptotic bodies and chromatin condensation. Ammonia 
could provide a link between energy metabolism and apoptosis where the progress of 
these events upon glutamine starvation is compromised. For example, ammonia can be 
used as a nitrogen donor instead of glutamine for the conversion of D-fructose-6P 
(Fru6P) into D-glucosamine-6P, a reaction of hexosamine metabolism, catalyzed by 
Glucosamine-6P synthase (GlmS) (266). The end product of this pathway is UDP-N-
acetyl glucosamine. In addition, DON has been shown to bind to the inactive 
glutaminase active site, leading to conformational change exposing the ammonia 
channel activation of the enzyme (266-268). This might, in part, promote the production 
of UDP-N-acetyl-glucosamine and would explain the significant improvement of cell 
viability when a combination of ammonium ions and DON was used (Figure 3-19). 
 
In conclusion, our data show that ammonia ions partially protected glutamine-starved 
Sp2/0 cells from apoptosis. The fact that the combined treatment of ammonium ions 
with a glutamine analog improved cell viability to the level of glutamine-fed cells, a 
phenomenon accompanied by the inhibition of caspase activation, was unexpected and 
is very interesting. The development of more specific glutaminase (GLS) inhibitors such 
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as BPTES and 968, which were shown to halt glutaminolysis, has recently triggered a 
renewed interest in the use of glutamine analogs for cancer therapy (34,54,61,269-271).  
Further studies are required to investigate the effect of ammonium ions supplementation 
on glutamine-deprived cells.  
 
4.4 Future work 
I have established that the molecular mechanism underlying the protective effect of 
ammonium ions against glutamine-starvation-induced apoptosis is influenced by the 
presence of a glutamine analog. Whether or not the intrinsic apoptosis pathway is 
modulated by the combination of ammonium salts and glutamine analog is an important 
question that remains to be answered. It would be interesting to see whether 
cytochrome c was released from the mitochondria when Sp2/0 cells were co-treated 
with glutamine analog and ammonium ions. Whether BCL-2 proteins (and in particular 
MCL-1) are modulated (protein levels, protein-protein interactions, intracellular 
localization, post-translational modification) by ammonium ions and glutamine analogs 
should also be investigated. Additionally, whether autophagy is at play is not entirely 
clear.  It has been established that autophagy and apoptosis are interconnected at 
different levels (272). For example, mTOR is involved in both processes (273,274), and 
caspase-9 and caspase-8 were found to mediate the cleavage of Beclin-1, a tumor 
suppressor and autophagy regulator, leading to inhibition of apoptosis (275-278). 
Although it was reported that ammonia stimulates autophagy independently of mTOR 
(161),  it was recently reported that ammonia stimulates autophagy by inhibiting mTOR 
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via dopamine receptor D3 (DRD3) (279). It would be interesting to see if either pathway 
occurs in our cell line. 
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6. Appendix 
 
Appendix A Solutions, buffers and their compositions. 
Solution/buffer Composition  
  
15x TBE buffer (1 L)                              154 g Tris base 
527.5 g Boric acid 
420 ml 0.5 M EDTA pH 8.0 
  
 200 mM Glutamine (10ml in PBS) 0.2922 g Glutamine 
Adjust pH to 7.2-7.4 
Filtered and stored at 4o C 
10X PBS (1 L) 800 ml ultrapure water 
80 g NaCl 
2 g KCl 
14.4 g Na2HPO4 
2.4 g KH2PO4 
Adjust pH to 7.4 with HCl. 
1X PBS (1 L) Adjust pH to 7.4 with HCl. 
Bring volume to 1 liter100 ml 10x PBS 
900 ml ddH2O 
  
10 x PBS (30 ml) (Cytosolic fraction  
Isolation) 
0.041 g NaH2PO4 
0.341 g Na2HPO4 
  
Solution A (Cytosolic fraction Isolation) (1 
ml ) 
100 µl of 10 x Digitonin solution  
900 µl of Solution B 
  
10X Digitonin (1 ml) 2.5 mg Digitonin 
1 ml Solution B 
  
Solution B (30 ml)   
(Cytosolic protein isolation) 
3 ml 10x phosphate butter 
0.168 g KCl (final concentration: 75 mM) 
9.23 g sucrose  
  
5  M Ammonium Acetate (10 ml in PBS) 3.85 g Ammonium Acetate 
Adjust pH to 7.4 with HCl 
  
5 M Ammonium chloride (10 ml in PBS) 2.67 g  Ammonium chloride 
Adjust pH to 7.4 with HCl 
  
1 M Sodium Chloride (10 ml in PBS) 0.584 g Sodium chloride 
Adjust pH to 7.4 with HCl 
  
1 M Sodium Acetate (10 ml in PBS)  1.360 g Sodium Acetate 
Adjust pH to 7.4 with HCl 
  
1M Dimethyl 2-oxoglutarate (1 ml) 15 µl  Dimethyl 2-oxoglutarate (9.6 M) 
1985 µl absolute Ethanol 
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Solution/buffer Composition  
10 mM Methyl pyruvate (1 ml) 100 µl of 100 mM Methyl Pyruvate 
900 µl PBS 
  
5 M Methylamine hydrochloride (10 ml in 
PBS) 
3.376 g Methylamine hydrochloride  
  
200 mM Methionine sulfoximine (1 ml in 
PBS) 
36.046 mg Methionine sulfoximine 
  
200 mM glutamate (10 ml n PBS)  0.29426 g Glutamate 
  
1 mM AZA (1 ml in PBS) 3.45 µl AZA 
  
1mM DON (1 ml in PBS) 20 µl DON (50 mM) 
  
Annexin V Binding Buffer (100 ml) 
 
10 mM Hepes (238.3 mg)  
aAdjust to pH 7.4 
140 mM NaCl  (818.1 mg) 
2.5 mM CaCl2   (36.75 mg) 
  
DNA fragmentation lysis buffer (10 ml) 0.1 ml of 1 M Tris-HCl, pH 8.0 
0.02 ml of 0.5 M EDTA, pH 8.0 
50 mg of N-lauroyl sarcosine 
1.0 ml of 2 mg/ml RNase A stock 
2.5 mg of Proteinase K 
Loading buffer(DNA) 040% sucrose 
0.08% Bromophenol Blue 
SDS-PAGE 
30% Acrylamide Stock solution: (50 ml)  29.2 % Acrylamide 
 0.8 % Bisacrylamide 
  
4X Tris/SDS pH 8.8 (100ml) 18.16 g Tris HCl 
2ml of 20% SDS  
pH to 8.8 
  
4X Tris/SDS pH 6.8  (50 ml) 
 
T9.0885 g Tris-HCl 
40 ml H2O pH 6.8 
0.2 g  SDS  
  
5X electrophoresis buffer (1L)  15.1 g Tris base 
72 g Glycine 
 5 g SDS 
  
Coomassie blue staining solution (250 ml) 
 
50 %methanol 
0.05 % Coomassie Brilliant Blue; 
10 % Acetic Acid 
40 % H2O 
  
  
  
  
  
De-staining Solution 
 
50 % Methanol 
10 % Acetic Acid 
40 % H2O  
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Solution/buffer Composition  
6X Sample Buffer (10 ml) 7 ml  4X Tris/SDS pH 6.8 
3.8 g  Glycerol  
1 g SDS  
0.6 ml 2-mercaptoethanol 
2 mg Bromophenol blue 
Urea Lysis Buffer (10 ml)  
 
1 g Glycerol 
1 ml of H2O and vortex 
3.606 g of Urea 
625 µl 1M Tris-HC1 pH 6.8 
l      ml H2O 
500 µl β-mercaptoethanol 
1     ml 20% SDS 
100 µl  Bromophenol Blue 
100 µl PMSF (10 mg/ml in Me0H) 
500 µl 1M NaF 
400 µl 50 mM Orthovanadate 
  
10% APS (10 ml) 1g Ammonium persulfate 
  
1x TTBS (1 L) 100 ml 10x TBS 
900 ml ddH2O 
  
Blocking buffer 1x TTBS 
5% BSA 
SDS-PAGE running buffer 25 mM Tris-HCl pH 8.3 
190 mM Glycine 
0.1% SDS 
  
Ponceau-S staining solution  ( 1  L )  1g Ponceau S 
50 ml Acetic acid  
Make up to 1L with ddH2O 
  
Transfer buffer (800 ml, /o methanol) 500 ml ddH2O 
5.82 g  Tris 
2.93 Glycine 
0.373 g SDS 
  
2X RIPA (9 ml) 
 
 
 
6 ml 3X PBS 
180 µl IGEPAL 
0.09 g Sodium Deoxycholate 
90  µl SDS (from 20% stock solutions) 
Complete to 9ml with H2O 
  
1X RIPA (1 ml) 
 
500 µl 2X RIPA 
100 µl Proteinase Inhibitor Cocktail  
50   µl NaF 1M 
4     µl Orthovanadate 50 mM 
10   µl PMSF (10mg/ml) 
336 µl H2O 
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Solution/buffer Composition  
Tris-Tricine SDS  
  
Tris·Cl/SDS, pH 8.45 (50 ml) 18.2 g   Tris base 
pH to 8.45 with HCl 
30 ml  H2O 
.15 g  SDS30 ml 
  
4X Tris-Cl/SDS pH 6.8  (100 ml) 6.05 g Tris base in 40 ml dd-water 
Adjust pH to 6.8 with 1 N HCl. 
Bring volume to 100 ml with dd-water. 
Add 0.4 g SDS  
  
2X Tricine Sample Buffer (10ml) 2 ml  4X Tris·HCl/SDS, pH 6.8 
3 g  Glycerol 
0.8 g SDS 
0.31 g DTT 
2 mg Coomassie Blue 
  
5x Anode Buffer pH 8.9 (1 L) 121.1 g Tris base 
500 ml H2O 
Add  H2O to 1 liter  
1x Cathode Buffer (1 L) 
  
 
 
12.11 g Tris 
17.92 g Tricine  
1 g   SDS 
Add      H2O to 1 liter 
  
10X TBS (1L) 
 
24.23 g Trizma HCl 
80.06 g NaCl 
Mix in 800 ml ultra pure water. 
pH to 7.6 with HCl. 
Top up to 1 L. 
 
 
 
 
 
 
 
 
  
133 
 
Appendix B Dose response of different concentrations of DON and AZA 
A) 
 
 
B) 
 
0
10
20
30
40
50
60
70
80
90
100
 PBS DON (1 µM) DON (10 µM)
P
e
rc
e
n
t 
m
e
m
b
ra
n
e
-i
n
ta
c
t 
c
e
lls
Gln + Gln -
0
10
20
30
40
50
60
70
80
90
100
 PBS AZA (2 µM) AZA (10 µM) AZA (20 µM)
P
e
rc
e
n
t 
m
e
m
b
ra
n
e
-i
n
ta
c
t 
c
e
lls
Gln + Gln -
  
134 
 
 
 
Appendix C Flow cytometry data show early and late apoptotic cells 
 - Gln + Gln 
 
Viable 
Early 
Apoptotic 
Late 
Apoptotic 
Necrotic Viable 
Early 
Apoptotic 
Late 
Apoptotic 
Necrotic 
AA 55.8±10.2 5.3± 6 38.7±11.2 0.1± 0.1 89.0±1.2 0.3±0.5 9.4±2.2 0.1±0.2 
AC 48.4±8.5 4.7±5.7 46.8±11.1 0.0±0.1 87.7±1.5 0.6±0.7 10.0±2.4 0.2±0.3 
SA 34.5±8.1 9.1±8.8 56.3±10.9 0.0±0.0 88.3±1.4 0.7±0.8 9.3±1.4 0.0±0.0 
SC 29.5±8.1 7.2±8.9 63.2±10.6 0.0±0.0 87.5±1.2 0.5±0.7 10.3±2.2 0.03±0.0 
PBS 29.6±8.0 8.9±11.3 46.8±12.1 0.0±0.0 86.7±2.5 0.5±0.9 10.3±1.5 0.0±0.0 
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Appendix D A representation of Flow cytometry data (Figure 3.12) 
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Appendix E A representation of Flow cytometry data (Figure 3.13) 
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Appendix F Densitometry for DON Western blot experiment (Figure 3.24) 
 
Values of Western blot bands are expressed relative to the loading control, Coomassie 
Blue. 
 
B) 
Sample 
DON/CASP3 (-Gln) DON 
(-Gln) 
PBS 
(-Gln) AA SA 
1 1.2 0.96 1.0 1.2 
2 2.5 2.8 2.8 3.0 
3 0.9 1.2 1.2 1.2 
 
Sample 
DON/CASP3 (-Gln) DON 
(-Gln) 
PBS 
(-Gln) AC SC 
1 1.1 1.0 0.8 0.8 
2 3.1 3.3 4.0 3.2 
3 5.0 6.4 5.0 7.4 
 
C) 
Sample 
DON/LAMIN (-Gln) DON 
(-Gln) 
PBS 
(-Gln) AA SA 
1 3.1 3.4 4.0 3.7 
2 3.2 7.0 7.1 8.1 
3 0.3 0.6 0.5 1.0 
 
Sample 
DON/LAMIN (-Gln) DON 
(-Gln) 
PBS 
(-Gln) AC SC 
1 2.2 2.4 2.3 2.5 
2 2.3 2.2 2.0 2.3 
3 2.9 3.0 2.8 3.1 
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Appendix G Densitometry for AZA Western blot experiment (Figure 3.25) 
Values of Western blot bands are expressed relative to the loading control, Coomassie 
Blue. 
 
B) 
Sample 
AZA/CASP3 (-Gln) AZA 
(-Gln) 
PBS 
(-Gln) AA SA 
1 1.7 2.3 2.0 2.4 
2 1.0 1.2 1.5 1.5 
3 4.6 4.5 4.2 4.9 
 
Sample 
AZA/CASP3 (-Gln) AZA 
(-Gln) 
PBS 
(-Gln) AC SC 
1 1.6 1.9 1.1 1.1 
2 0.94 0.8 0.6 0.8 
3 2.0 4.9 5.7 4.1 
 
C) 
Sample 
AZA/LAMIN (-Gln) AZA 
(-Gln) 
PBS 
(-Gln) AA SA 
1 4.4 5.0 4.9 5.5 
2 3.4 4.2 4.4 4.4 
3 3.6 6.5 5.6 6.1 
 
Sample 
AZA/LAMIN (-Gln) AZA 
(-Gln) 
PBS 
(-Gln) AC SC 
1 3.0 3.2 3.3 3.2 
2 2.7 2.2 2.2 2.2 
3 3.9 4.6 5.0 7.5 
